Home
  >  
Section 41

EurekaMag Full Text Articles Chapter 40,997



References:

George, J.N. 1976: Platelet membrane glycoproteins: alteration during storage of human platelet concentration. Thrombosis Research 8(5): 719-724
Roche Asensio, M.J.; Faure Nogueras, E.; Cuesta Muñoz, J.; Blasco Comenge, M.C.; Gutiérrez Martín, M. 1986: Platelet membrane glycoproteins: their correlation with the degree of metabolic compensation in the diabetic patient. Medicina Clinica 87(11): 453-455
Boué, D.; Viratelle, O.M. 1992: Platelet membrane phosphatidylinositol kinase activity. Triton X-100 effects provide evidence for intramicellar reaction. Biochimica et Biophysica Acta 1103(1): 120-126
MacIntyre, D.E.; Montecucco, C.; Rink, T.J. 1979: Platelet membrane potential assessed with a fluorescent probe, dipropylthiadicarbocyanine: has this potential a role in triggering aggregation?. Journal of Physiology 289: 34P-35P
Pipili, E. 1985: Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. Thrombosis and Haemostasis 54(3): 645-649
Hicks, N.; Brammer, M.J.; Hymas, N.; Levy, R. 1987: Platelet membrane properties in Alzheimer and multi-infarct dementias. Alzheimer Disease and Associated Disorders 1(2): 90-97
Solum, N.O. 1985: Platelet membrane proteins. Seminars in Hematology 22(4): 289-302
Bearer, E.L. 1990: Platelet membrane skeleton revealed by quick-freeze deep-etch. Anatomical Record 227(1): 1-11
Asch, A.S.; Leung, L.L.; Polley, M.J.; Nachman, R.L. 1985: Platelet membrane topography: colocalization of thrombospondin and fibrinogen with the glycoprotein IIb-IIIa complex. Blood 66(4): 926-934
Green, D.; Potter, E.V. 1978: Platelet membrane von Willebrand factor:. Blood 52(4): 856-857
Carey, F.; Menashi, S.; Authi, K.S.; Hack, N.; Lagarde, M.; Crawford, N. 1985: Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores. Advances in Experimental Medicine and Biology 192: 185-199
Reuter, H.; Gross, R. 1978: Platelet metabolism. Supplementum .. Ad Thrombosis and Haemostasis 63: 87-95
Yeaman, M.R.; Norman, D.C.; Bayer, A.S. 1992: Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus. Antimicrobial Agents and ChemoTherapy 36(8): 1665-1670
White, J.G. 1978: Platelet microtubules and giant granules in the Chediak-Higashi syndrome. American Journal of Medical Technology 44(4): 273-278
Nishiki, M.; Maples, J.A.; Inboriboon, P.; Inboriboon, A.; Chao, W. 1976: Platelet migration inhibition test for platelet antibodies...parameters and simplified methodology. Hiroshima Journal of Medical Sciences 25(4): 187-189
Krige, D.; Carroll, M.T.; Cooper, J.M.; Marsden, C.D.; Schapira, A.H. 1992: Platelet mitochondrial function in Parkinson's disease. the Royal Kings and Queens Parkinson Disease Research Group. Annals of Neurology 32(6): 782-788
Castro-Faria-Neto, H.C.; Bozza, P.T.; Martins, M.A.; Dias, P.M.; Silva, P.M.; Cordeiro, R.S. 1989: Platelet mobilization induced by PAF and its role in the thrombocytosis triggered by adrenaline in rats. Thrombosis and Haemostasis 62(4): 1107-1111
Moon, D.G.; van der Zee, H.; Weston, L.K.; Gudewicz, P.W.; Fenton, J.W.; Kaplan, J.E. 1990: Platelet modulation of neutrophil superoxide anion production. Thrombosis and Haemostasis 63(1): 91-96
Murphy, D.L.; Donnelly, C.H.; Miller, L.; Wyatt, R.J. 1976: Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity. Archives of General Psychiatry 33(11): 1377-1381
Owen, F.; Bourne, R.; Crow, T.J.; Johnstone, E.C.; Bailey, A.R.; Hershon, H.I. 1976: Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients. Archives of General Psychiatry 33(11): 1370-1373
Jones, J.B.; Southgate, J. 1976: Platelet mono-amine oxidase activity in the human fetus. Developmental Medicine and Child Neurology 18(5): 640-642
Gershon, E.S.; Targum, S.D.; Leckman, J.F. 1979: Platelet monoamine oxidase (MAO) activity and genetic vulnerability to bipolar (BP) affective illness. Psychopharmacology Bulletin 15(1): 27-30
Rapkin, A.J.; Buckman, T.D.; Sutphin, M.S.; Chang, L.C.; Reading, A.E. 1988: Platelet monoamine oxidase B activity in women with premenstrual syndrome. American Journal of Obstetrics and Gynecology 159(6): 1536-1540
Flaskos, J.; Theophilopoulos, N.; George, A.J. 1989: Platelet monoamine oxidase activity and 5-hydroxytryptamine uptake in agoraphobic patients. British Journal of Psychiatry: the Journal of Mental Science 155: 680-685
Mendelson, W.B.; Buchsbaum, M.S.; Murphy, D.L.; Wyatt, R.J.; Gillin, J.C. 1978: Platelet monoamine oxidase activity and human sleep. Communications in Psychopharmacology 2(6): 539-544
Irving, J.B.; Coursey, R.D.; Buchsbaum, M.S.; Murphy, D.L. 1989: Platelet monoamine oxidase activity and life stress as predictors of psychopathology and coping in a community sample. Psychological Medicine 19(1): 79-90
Poirier, M.F.; Lôo, H.; Dennis, T.; Le Fur, G.; Scatton, B. 1985: Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycle. Neuropsychobiology 14(4): 165-169
Fleissner, A.; Seifert, R.; Schneider, K.; Eckert, W.; Fuisting, B. 1987: Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?. European Archives of Psychiatry and Neurological Sciences 237(1): 8-15
Cookson, I.B.; Owen, F.; Ridges, A.P. 1975: Platelet monoamine oxidase activity during the course of a schizophreniform psychosis. Psychological Medicine 5(3): 314-316
Mann, J.; Chiu, E. 1978: Platelet monoamine oxidase activity in Huntington's chorea. Journal of Neurology Neurosurgery and Psychiatry 41(9): 809-812
Carpenter, W.T.; Murphy, D.L.; Wyatt, R.J. 1975: Platelet monoamine oxidase activity in acute schizophrenia. American Journal of Psychiatry 132(4): 438-441
Mosnaim, A.D.; Huprikar, S.; Wolf, M.E.; Diamond, S. 1990: Platelet monoamine oxidase activity in female migraine patients. Headache 30(8): 488-490
Norman, T.R.; Chiu, E.; French, M.A. 1987: Platelet monoamine oxidase activity in patients with Huntington's disease. Clinical and Experimental Pharmacology and Physiology 14(6): 547-550
Gorman, J.; Liebowitz, M.R.; Fyer, A.J.; Levitt, M.; Baron, M.; Davies, S.; Klein, D.F. 1985: Platelet monoamine oxidase activity in patients with panic disorder. Biological Psychiatry 20(8): 852-857
Wyatt, R.J.; Potkin, S.G.; Murphy, D.L. 1979: Platelet monoamine oxidase activity in schizophrenia: a review of the data. American Journal of Psychiatry 136(4a): 377-385
Becker, R.E.; Shaskan, E.G. 1977: Platelet monoamine oxidase activity in schizophrenic patients. American Journal of Psychiatry 134(5): 512-517
Rossi, E.C.; Louis, G.; Bieber, M.; Zeller, E.A. 1978: Platelet monoamine oxidase and epinephrine-induced platelet aggregation. Thrombosis and Haemostasis 40(1): 37-42
Lykouras, E.; Moussas, G.; Markianos, M. 1987: Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in non-abstinent chronic alcoholics. Relation to clinical parameters. Drug and Alcohol Dependence 19(4): 363-368
Markianos, M.; Sfagos, C.; Bistolaki, E. 1991: Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in patients with multiple sclerosis. Acta Neurologica Scandinavica 84(6): 531-533
Sullivan, J.L.; Stanfield, C.N.; Schanberg, S.; Cavenar, J. 1978: Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activity in chronic alcoholics. Archives of General Psychiatry 35(10): 1209-1212
Poirier, M.F.; Lôo, H.; Lefur, G.; Mitrani, N. 1985: Platelet monoamine oxidase and sex hormones in a population of depressed patients. L'Encephale 11(3): 125-129
Lee, D.H.; Mendoza, M.; Dvorozniak, M.T.; Chung, E.; van Woert, M.H.; Yahr, M.D. 1989: Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1(3): 189-194
Ask, A.L.; Böök, J.A.; Heyden, T.; Ross, S.B.; Unge, C.; Wetterberg, L.; Eiduson, S.; Kobayashi, K. 1979: Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project. Clinical Genetics 15(4): 289-299
Edwards, D.J.; Spiker, D.G.; Kupfer, D.J.; Foster, G.; Neil, J.F.; Abrams, L. 1978: Platelet monoamine oxidase in affective disorders. Archives of General Psychiatry 35(12): 1443-1446
Boullin, D.J.; Bhagavan, H.N.; Coleman, M.; O'Brien, R.A.; Youdim, M.B. 1975: Platelet monoamine oxidase in children with infantile autism. Medical Biology 53(4): 210-213
Berrettini, W.H.; Vogel, W.H.; Clouse, R. 1977: Platelet monoamine oxidase in chronic schizophrenia. American Journal of Psychiatry 134(7): 805-807
Berger, P.A.; Ginsburg, R.A.; Barchas, J.D.; Murphy, D.L.; Wyatt, R.J. 1978: Platelet monoamine oxidase in chronic schizophrenic patients. American Journal of Psychiatry 135(1): 95-99
Cohen, D.J.; Young, J.G.; Roth, J.A. 1977: Platelet monoamine oxidase in early childhood autism. Archives of General Psychiatry 34(5): 534-537
Belmaker, R.H.; Ebbesen, K.; Ebstein, R.; Rimon, R. 1976: Platelet monoamine oxidase in schizophrenia and manic-depressive illness. British Journal of Psychiatry: the Journal of Mental Science 129: 227-232
Marcolin, M.A.; Davis, J.M. 1992: Platelet monoamine oxidase in schizophrenia: a meta-analysis. Schizophrenia Research 7(3): 249-267
Feine, R.; Belmaker, R.H.; Rimon, R.; Ebstein, R.P. 1977: Platelet monoamine oxidase in women with premenstrual syndrome. Neuropsychobiology 3(2-3): 105-110
Simpson, G.M.; Frederickson, E.; Palmer, R.; Pi, E.; Sloane, R.B.; White, K. 1985: Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use. Biological Psychiatry 20(6): 684-687
Buffoni, F.; Ignesti, G.; Pirision, R.; Cortesini, C. 1977: Platelet monoamine oxidase, plasma benzylamine oxidase and liver mixed function oxidase in cirrhotic patients. Medical Biology 55(2): 109-111
Lykouras, E.; Markianos, M.; Moussas, G. 1989: Platelet monoamine oxidase, plasma dopamine beta-hydroxylase activity, dementia and family history of alcoholism in chronic alcoholics. Acta Psychiatrica Scandinavica 80(5): 487-491
Buchsbaum, M.S.; Murphy, D.L.; Coursey, R.D.; Lake, C.R.; Zeigler, M.G. 1978: Platelet monoamine oxidase, plasma dopamine-beta-hydroxylase and attention in a "biochemical high risk" sample. Journal of Psychiatric Research 14(1-4): 215-224
Steventon, G.B.; Sturman, S.G.; Heafield, M.T.; Waring, R.H.; Napier, J.; Williams, A.C. 1989: Platelet monoamine oxidase-B activity in Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1(4): 255-261
Wise, C.D.; Bridge, T.P.; Potkin, S.G.; Wyatt, R.J. 1979: Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups. Psychiatry Research 1(2): 187-190
Kemali, D.; Maj, M.; Ariano, M.G.; Salvati, A. 1985: Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs. L'Encephale 11(1): 31-34
Castrogiovanni, P.; Maremmani, I.; Bongioanni, P.; Marazziti, D. 1990: Platelet monoaminooxidase activity and behavioural characteristics in humans. Neuropsychobiology 23(4): 173-176
Hensler, M.E.; Frojmovic, M.; Taylor, R.G.; Hantgan, R.R.; Lewis, J.C. 1992: Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets. American Journal of Pathology 141(3): 707-719
Hattori, A.; Jinbo, C. 1976: Platelet morphology and function--adhesion, aggregation and release reaction. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 39(5): 633-652
Hattori, A.; Nagayama, R.; Koike, T.; Hanano, M.; Shibata, A.; Kojima, T. 1985: Platelet morphology as an indicator of platelet activation--with special reference to methods of determining platelet shape and results. Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 62: 5-18
D'Andrea, G.; Welch, K.M.; Grunfeld, S.; Joseph, R.; Nagel-Leiby, S. 1989: Platelet norepinephrine and serotonin balance in migraine. Headache 29(10): 657-659
García-Conde, J.; Benet, I.; Merino, J. 1977: Platelet osmotic shock. I. Assessment and ultrastructural changes. Sangre 22(3): 313-323
Baynes, R.D.; Lamparelli, R.D.; Bezwoda, W.R.; Gear, A.J.; Chetty, N.; Atkinson, P. 1988: Platelet parameters. Part II. Platelet volume-number relationships in various normal and disease states. South African Medical Journal 73(1): 39-43
Durham, S.K.; Horan, M.A.; Brouwer, A.; Barelds, R.J.; Knook, D.L. 1989: Platelet participation in the increased severity of endotoxin-induced pulmonary injury in aged rats. Journal of Pathology 157(4): 339-345
Bonuccelli, U.; Nuti, A.; Del Dotto, P.; Piccini, P.; Martini, C.; Giannaccini, G.; Lucacchini, A.; Muratorio, A. 1991: Platelet peripheral benzodiazepine receptors are decreased in Parkinson's disease. Life Sciences 48(12): 1185-1190
Kawaguchi, M.; Nakano, M.; Enomoto, Y.; Watanabe, Y.; Toyama, K. 1990: Platelet peroxidase-like activity detected in mature erythroblasts from a patient with pernicious anemia. American Journal of Hematology 33(4): 267-270
Suda, J.; Eguchi, M.; Ozawa, T.; Furukawa, T.; Hayashi, Y.; Kojima, S.; Maeda, H.; Tadokoro, K.; Sato, Y.; Miura, Y. 1988: Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome. British Journal of Haematology 68(2): 181-187
Jaff, M.S.; McKenna, D.; McCann, S.R. 1985: Platelet phagocytosis: a probable mechanism of thrombocytopenia in Plasmodium falciparum infection. Journal of Clinical Pathology 38(11): 1318-1319
Vergracht, A.; Valentin, N.; Bignon, J.D.; Patereau, C.; Muller, J.Y. 1988: Platelet phenotyping and study of alloantibodies using flow cytometry. Revue Francaise de Transfusion et Immuno-Hematologie 31(5): 697-709
Arrell, H.M. 1987: Platelet pheresis. Nursing 17(8): 92-93
Limon, I.; Blanc, J.; Koutouzov, S.; Knorr, A.; Meyer, P.; Marche, P. 1990: Platelet phospholipase C activity in salt-dependent hypertension. Hypertension 15(4): 381-387
Rauch, J. 1990: Platelet phospholipid antigen-antibody interactions: detection and biological relevance. Transfusion Medicine Reviews 4(2): 110-114
Ciavatti, M.; Michel, G.; Dechavanne, M. 1978: Platelet phospholipid in stroke. Clinica Chimica Acta; International Journal of Clinical Chemistry 84(3): 347-351
Kaulen, H.D.; Gross, R. 1975: Platelet phospholipid synthesis during thrombin-induced platelet aggregation. Thrombosis et Diathesis Haemorrhagica 34(2): 595
Kanof, P.D.; Mohs, R.C.; Gross, J.; Davidson, M.; Bierer, L.M.; Davis, K.L. 1991: Platelet phospholipid synthesis in Alzheimer's disease. Neurobiology of Aging 12(1): 65-69
Aktulga, A.Z.; Gürakar, M.; Ulutin, O.N. 1977: Platelet phospholipids in liver cirrhosis. Acta Hepato-Gastroenterologica 24(6): 411-414
Weiss, H.J. 1975: Platelet physiology and abnormalities of platelet function (second of two parts). New England Journal of Medicine 293(12): 580-588
Rengasamy, A.; Feinberg, H. 1988: Platelet plasma membrane calcium release by inositol 1,4,5-trisphosphate. Progress in Clinical and Biological Research 283: 519-522
Phillips, D.R.; Agin, P.P. 1977: Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin. Biochemical and Biophysical Research Communications 75(4): 940-947
Launay, J.M. 1992: Platelet plasma membrane: characterization of the serotonin transporter. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 186(3): 198-205
Fay, W.P.; Owen, W.G. 1989: Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C. Biochemistry 28(14): 5773-5778
Chalker, R.B.; Blaser, M.J. 1987: A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Reviews of Infectious Diseases 10(1): 111-124
Eason, C.T.; Pattison, A.; Howells, D.D.; Mitcheson, J.; Bonner, F.W. 1986: Platelet population profiles: significance of species variation and drug-induced changes. Journal of Applied Toxicology: Jat 6(6): 437-441
Odink, J.; Brank, A. 1977: Platelet preservation V. Survival, serotonin uptake velocity, and response to hypotonic stress of fresh and cryopreserved human platelets. Transfusion 17(3): 203-209
Van Oeveren, W.; Eijsman, L.; Roozendaal, K.J.; Wildevuur, C.R. 1988: Platelet preservation by aprotinin during cardiopulmonary bypass. Lancet 1(8586): 644
Wildevuur, C.R.; Eijsman, L.; Roozendaal, K.J.; Harder, M.P.; Chang, M.; van Oeveren, W. 1989: Platelet preservation during cardiopulmonary bypass with aprotinin. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 3(6): 533-537; Discussion: 537-538
Palatianos, G.M.; Dewanjee, M.K.; Smith, W.; Novak, S.; Hsu, L.C.; Kapadvanjwala, M.; Sfakianakis, G.N.; Kaiser, G.A. 1991: Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-Ii heparin-coated surfaces. Asaio Transactions 37(4): 620-622
Addonizio, V.P.; Colman, R.W.; Edmunds, L.H. 1978: Platelet preservation during in vitro extracorporeal circulation by albumin adsorption. Surgical Forum 29: 289-290
Odink, J.; Sprokholt, R. 1977: Platelet preservation. I. the use of decrease in light absorbance as a screening method in cryopreservation studies on human platelets. Cryobiology 14(5): 519-528
Odink, J. 1976: Platelet preservation. II. the response of human platelet suspensions to hypotonic stress. Thrombosis and Haemostasis 36(1): 182-191
Odink, J.; Sprokholt, R. 1976: Platelet preservation. III. the influence of dimethylsulfoxide and cooling conditions on serotonin uptake velocity and response to hypotonic stress of human platelets. Thrombosis and Haemostasis 36(1): 192-199
Odink, J.; de Wit, J.J.; Janssen, C.L.; Prins, H.K. 1978: Platelet preservation. IV. Preparation and cryopreservation of platelet concentrates from fresh and overnight-stored human blood. Transfusion 18(1): 21-28
Chong, B.H.; Castaldi, P.A. 1986: Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia. Australian and New Zealand Journal of Medicine 16(5): 715-716
Quadri, M.I.; Das, K.C.; Mohanty, D. 1988: Platelet procoagulant activity and heterologous antiplatelet antibody. Indian Journal of Medical Research 88: 505-508
Armani, U.; Piana, A.; Ravera, D. 1979: Platelet production in humans and dogs. Archivio "e. Maragliano" di Patologia E Clinica 35(2): 67-72
McDonald, T.P. 1978: Platelet production in hypoxic and RBC-transfused mice. Scandinavian Journal of Haematology 20(3): 213-220
Martin, J.F.; Slater, D.N.; Trowbridge, E.A. 1987: Platelet production in the lungs. Agents and Actions. Supplements 21: 37-57
Sugiyama, T.; Okuma, M.; Uchino, H. 1986: Platelet prostaglandin D2 dehydrogenase in patients with myeloproliferative disorders. Prostaglandins Leukotrienes and Medicine 21(2): 207-220
Kaiya, H.; Ofuji, M.; Nozaki, M.; Tsurumi, K. 1990: Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation. Psychopharmacology Bulletin 26(3): 381-384
Ofuji, M.; Kaiya, H.; Nozaki, M.; Tsurumi, K. 1989: Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets. Life Sciences 45(22): 2135-2140
Van Nostrand, W.E.; Schmaier, A.H.; Farrow, J.S.; Cunningham, D.D. 1991: Platelet protease nexin-2/amyloid beta-protein precursor. Possible pathologic and physiologic functions. Annals of the new York Academy of Sciences 640: 140-144
Gerrard, J.M.; Friesen, L.L.; McCrea, J.M.; Israels, S.J.; Robinson, P. 1985: Platelet protein phosphorylation. Advances in Experimental Medicine and Biology 192: 235-248
Brooks, S.F.; Gordge, P.C.; Toker, A.; Evans, A.T.; Evans, F.J.; Aitken, A. 1990: Platelet protein phosphorylation and protein kinase C activation by phorbol esters with different biological activity and a novel synergistic response with Ca2+ ionophore. European Journal of Biochemistry 188(2): 431-437
Hanai, K.; Kato, H.; Matsuhashi, S.; Morita, H.; Raines, E.W.; Ross, R. 1987: Platelet proteins, including platelet-derived growth factor, specifically depress a subset of the multiple components of the response elicited by glutathione in Hydra. Journal of Cell Biology 104(6): 1675-1681
Crook, M. 1990: Platelet prothrombinase in health and disease. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(2): 167-174
Mocchi, N.; Mercantini, F. 1989: Platelet pseudomicrocytosis and cryoglobulinemia. Haematologica 74(2): 223
Bertolini, F.; Rebulla, P.; Porretti, L.; Murphy, S. 1992: Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium. Transfusion 32(1): 9-16
Horton, R.W.; Katona, C.L.; Theodorou, A.E.; Hale, A.S.; Davies, S.L.; Tunnicliffe, C.; Yamaguchi, Y.; Paykel, E.S.; Kelly, J.S. 1986: Platelet radioligand binding and neuroendocrine challenge tests in depression. Ciba Foundation Symposium 123: 84-105
Inyang, A.L.; Sodeinde, O.; Okpako, D.T.; Essien, E.M. 1987: Platelet reactions after interaction with cultured Plasmodium falciparum infected erythrocytes. British Journal of Haematology 66(3): 375-378
Joist, J.H.; Pennington, D.G. 1987: Platelet reactions with artificial surfaces. Asaio Transactions 33(3): 341-344
Schrör, K. 1990: Platelet reactivity and arachidonic acid metabolism in type Ii hyperlipoproteinaemia and its modification by cholesterol-lowering agents. Eicosanoids 3(2): 67-73
Louden, K.A.; Broughton Pipkin, F.; Heptinstall, S.; Fox, S.C.; Mitchell, J.R.; Symonds, E.M. 1991: Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. British Journal of Obstetrics and Gynaecology 98(12): 1239-1244
De Sousa, J.R.; Santos, M.C.; Carlos, M.L.; Carlos, A.G. 1992: Platelet reactivity to "in vitro" allergen challenge in asthmatic patients. Allergologia et Immunopathologia 20(1): 13-16
Hawiger, J.; Kloczewiak, M.; Bednarek, M.A.; Timmons, S. 1989: Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis. Biochemistry 28(7): 2909-2914
Ahmad, S.S.; Rawala-Sheikh, R.; Ashby, B.; Walsh, P.N. 1989: Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIIi are deficient on platelets in Scott syndrome. Journal of Clinical Investigation 84(3): 824-828
Clemetson, K.J. 1991: Platelet receptors and functional disorders. Schweizerische Medizinische Wochenschrift. Supplementum 43: 12-23
Kao, K.J.; Pizzo, S.V.; McKee, P.A. 1979: Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation. Proceedings of the National Academy of Sciences of the United States of America 76(10): 5317-5320
Detwiler, T.C.; McGowan, E.B. 1985: Platelet receptors for thrombin. Advances in Experimental Medicine and Biology 192: 15-28
Beer, J.H. 1992: Platelet receptors: nomenclature--structure--function. 1. Schweizerische Medizinische Wochenschrift 122(34): 1249-1263
Beer, J.H. 1992: Platelet receptors: nomenclature--structure--function. 2. Schweizerische Medizinische Wochenschrift 122(35): 1287-1304
Boneu, A.; Sié, P.; Bugat, R.; Caranobe, C.; Eber, M.; Cazenave, J.P.; Boneu, B. 1985: Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study. Thrombosis and Haemostasis 53(2): 260-263
Rosenberg, J.C.; Sell, T. 1975: Platelet release and aggregation induced by antithymocyte globulin. in vitro effect of inhibitors. Transplantation 20(4): 346-350
Pradalier, A.; Launay, J.M.; Soliman, M.; Dreux, C.; Guittard, M.; Hanna, K.M.; Dry, J. 1987: Platelet release of dopamine in the common migraine attack. Presse Medicale 16(27): 1321-1323
Ikeda, Y.; Watanabe, K.; Ando, Y. 1979: Platelet release reaction and calcium ions. Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 40: 74-82
Weiss, A.; Baenziger, N.L.; Atkinson, J.P. 1978: Platelet release reaction and intracellular cGMP. Blood 52(3): 524-531
Høgevold, H.E.; Mundal, H.H.; Norman, N.; Reikerås, O. 1990: Platelet release reaction and plasma catecholamines during total hip replacement. no effects of high doses of corticosteroids. Thrombosis Research 57(1): 21-29
Matsuda, T. 1985: Platelet release reactions: progress of research and clinical implications. Nihon Rinsho. Japanese Journal of Clinical Medicine 43(5): 1065-1072
Hester, J.P.; McCredie, K.B.; Freireich, E.J. 1978: Platelet replacement therapy: a clinical assessment. Progress in Clinical and Biological Research 28: 281-293
Manrique, R.V.; Manrique, V. 1987: Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline. Angiology 38(2 Part 1): 101-108
Cooper, B.; Schafer, A.I.; Puchalsky, D.; Handin, R.I. 1978: Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders. Blood 52(3): 618-626
Fiedel, B.A. 1988: Platelet response to aggregated C-reactive protein: fibrinogen-dependent and independent signals. Immunology 63(1): 169-170
Stehbens, W.E. 1991: Platelet response to intravenous lipid emulsions. American Journal of Clinical Nutrition 54(2): 431-432
Tanaka, K.; Nagafuchi, Y. 1979: Platelet response to laser-induced vascular injury in rats--electron microscope study. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(3): 556-558
Kolobow, T.; Tomlinson, T.; Pierce, J.; Gattinoni, L. 1976: Platelet response to long-term spiral coiled membrane lung bypass without heparin using a carbon silicone rubber membrane. Transactions - American Society for Artificial Internal Organs 22: 110-118
Magilligan, D.J.; Schwartz, S.I. 1975: Platelet response to regional and systemic shock. Surgery 77(2): 268-274
Anderson, G.H.; Hellums, J.D.; Moake, J.; Alfrey, C.P. 1978: Platelet response to shear stress: changes in serotonin uptake, serotonin release, and ADP induced aggregation. Thrombosis Research 13(6): 1039-1047
Yardumian, D.A.; Mackie, I.J.; Bull, H.; Machin, S.J. 1985: Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374. Advances in Prostaglandin Thromboxane and Leukotriene Research 13: 359-362
Zoccarato, F.; Ruzzene, M.; Cavallini, L.; Doni, M.G.; Francesconi, M.A.; Deana, R.; Alexandre, A. 1991: Platelet responses promoted by the activation of protein kinase C or the increase of cytosolic Ca2+ are potentiated by adrenaline. Effects of cAMP and staurosporine. Biochimica et Biophysica Acta 1092(1): 72-78
Neiman, J.; Rand, M.L.; Jakowec, D.M.; Packham, M.A. 1989: Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. Thrombosis Research 56(3): 399-405
Silberbauer, K.F.; Sinzinger, H.; Ring, F.; Willvonseder, R.; Weissel, M. 1977: Platelet retention and hypothyroidism: an investigation in patients with thyroid carcinoma treated by total thyroidectomy. Wiener Klinische Wochenschrift 89(17): 590-594
Coleman, D.L.; Atwood, A.I.; Andrade, J.D. 1976: Platelet retention by albuminated glass and polystyrene beads. Journal of Bioengineering 1(1): 33-44
McPherson, J.; Zucker, M.B. 1976: Platelet retention in glass bead columns: adhesion to glass and subsequent platelet-platelet interactions. Blood 47(1): 55-67
Goldsmith, H.L.; Rifkin, P.L.; Zucker, M.B. 1975: Platelet retention test: accumulation of corpuscles at the advancing blood--air interface. Microvascular Research 9(3): 304-309
Fitzpatrick, F.A.; Gorman, R.R. 1977: Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2. Prostaglandins 14(5): 881-889
Astafieva, N.G. 1990: Platelet role in pathogenesis of atopic and nonimmunologic asthma. Allergologia et Immunopathologia 18(1): 19-26
White, L.A.; Brubaker, L.H.; Aster, R.H.; Henry, P.H.; Adelstein, E.H. 1978: Platelet satellitism and phagocytosis by neutrophils: association with antiplatelet antibodies and lymphoma. American Journal of Hematology 4(4): 313-323
Skinnider, L.F.; Musclow, C.E.; Kahn, W. 1978: Platelet satellitism--an ultrastructural study. American Journal of Hematology 4(2): 179-185
Fábryová, V.; Bürgi, W.; Brugger, E. 1991: Platelet satellitosis. Vnitrni Lekarstvi 37(6): 563-571
Steiner, T. 1977: Platelet satellitosis and other in vitro changes induced by EDTA. West Virginia Medical Journal 73(12): 322-325
Ahmed, P.; Minnich, V.; Michael, J.M. 1978: Platelet satellitosis with spurious thrombocytopenia and neutropenia. American Journal of Clinical Pathology 69(4): 473-474
Kessler, C.; Hipp, M.; Langkau, G.; Pawlik, G.; Petrovici, J.N. 1987: Platelet scintigraphy findings in carotid thrombosis following whiplash trauma of the cervical spine. Der Nervenarzt 58(7): 428-431
Maor, I.; Brook, G.J.; Aviram, M. 1991: Platelet secreted lipoprotein-like particle is taken up by the macrophage scavenger receptor and enhances cellular cholesterol accumulation. Atherosclerosis 88(2-3): 163-174
Mürer, E.H.; Davenport, K.; Day, H.J. 1975: Platelet secretion induced by calcium ionophores: effect of anti-inflammatory drugs. Thrombosis et Diathesis Haemorrhagica 34(2): 554
Aviram, M. 1989: Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages. Metabolism, Clinical and Experimental 38(5): 425-430
Davis, T.M.; Bown, E.; Turner, R.C. 1985: Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy. Diabetologia 28(5): 274-276
Gerö, G.; Rákóczi, I.; Tihanyi, K.; Oláh, J.; Demeter, J.; Gáti, I. 1985: Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies. Haemostasis 15(6): 377-383
Fitscha, P.; Kaliman, J.; Sinzinger, H. 1985: Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. American Journal of Hematology 19(1): 13-19
Pillay, P.K.; Pillay, U.; Balasubramaniam, P.; Lee, K.O. 1985: Platelet sensitivity to prostacyclin in diabetes mellitus. Annals of the Academy of Medicine Singapore 14(2): 229-231
Burghuber, O.C.; Punzengruber, C.; Sinzinger, H.; Haber, P.; Silberbauer, K. 1986: Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest 90(1): 34-38
Kloiber, R.; Poon, M.C.; Molnar, C.P. 1987: Platelet sequestration in a vascular malformation of Klippel-Trenaunay syndrome. Ajr. American Journal of Roentgenology 149(6): 1275-1277
Kim, S.M.; Park, C.H.; Thakur, M.L. 1987: Platelet sequestration in widespread pulmonary hemangiolymphangiectasia. Demonstration by indium-111 labeled platelets. Clinical Nuclear Medicine 12(3): 215-216
Engelfriet, C.P. 1986: Platelet serology: prospects and problems. Current Studies in Hematology and Blood Transfusion 52: 1-5
Mück-Seler, D.; Deanović, Z.; Dupelj, M. 1979: Platelet serotonin (5-HT) and 5-HT releasing factor in plasma of migrainous patients. Headache 19(1): 14-17
Davidenkova, E.F.; Grigor'eva, V.V.; Verlinskaia, D.K. 1979: Platelet serotonin absorption in Turner's syndrome. Problemy Endokrinologii 25(6): 28-31
Guicheney, P.; Baudouin-Legros, M.; Garnier, J.P.; Roques, P.; Dreux, C.; Meyer, P. 1985: Platelet serotonin and blood tryptophan in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Journal of Cardiovascular Pharmacology 7(Suppl 7): S15-S17
Quintana, J. 1992: Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations. Journal of Affective Disorders 24(2): 55-62
Joseph, M.H.; Owen, F.; Baker, H.F.; Bourne, R.C. 1977: Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients. Psychological Medicine 7(1): 159-162
De Villard, R.; Flachaire, E.; Laujin, A.; Maillet, J.; Revol, O.; Charles, S.; Mamelle, J.C.; Renaud, B.; Quincy, C. 1991: Platelet serotonin concentration in children under 5 years of age. Pediatrie 46(12): 813-816
Gow, I.F.; Jones, D.B.; Billett, J.; France, A.J.; Edwards, C.R. 1988: Platelet serotonin concentration in patients with finger-clubbing. Lancet 2(8610): 579
de Villard, R.; Flachaire, E.; Thoulon, J.M.; Dalery, J.; Maillet, J.; Chauvin, C.; Quincy, C.; Renaud, B. 1986: Platelet serotonin concentrations in autistic children and members of their families. L'Encephale 12(4): 139-142
Guicheney, P.; Léger, D.; Barrat, J.; Trévoux, R.; De Lignières, B.; Roques, P.; Garnier, J.P.; Boyer, P.; Grenier, J.; Dreux, C. 1988: Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms. European Journal of Clinical Investigation 18(3): 297-304
Baudouin-Legros, M.; Le Quan-Bui, K.H.; Guicheney, P.; Kamal, L.A.; Meyer, P. 1985: Platelet serotonin in essential hypertension and in mental depression. Journal of Cardiovascular Pharmacology 7(Suppl 7): S12-S14
Dollfus, S.; Petit, M.; Launay, J.M.; Callebert, J.; Boudou, P.; Dreux, C.; Ménard, J.F. 1992: Platelet serotonin in infantile autism. Cross-over effects of a dopamine agonist and an antagonist. L'Encephale 18(6): 605-610
McIntyre, I.M.; Norman, T.R. 1989: Platelet serotonin response to treatment in geriatric depression. Biological Psychiatry 26(4): 434-436
Norman, T.R.; Sartor, D.M.; Judd, F.K.; Burrows, G.D.; Gregory, M.S.; McIntyre, I.M. 1989: Platelet serotonin uptake and 3H-imipramine binding in panic disorder. Journal of Affective Disorders 17(1): 77-81
Malmgren, R.; Collins, A.; Nilsson, C.G. 1987: Platelet serotonin uptake and effects of vitamin B6-treatment in premenstrual tension. Neuropsychobiology 18(2): 83-86
Quintana, J. 1989: Platelet serotonin uptake dynamic changes in depression: effects of long-term imipramine treatment and clinical recovery. Journal of Affective Disorders 16(2-3): 233-242
Pandey, G.N.; Pandey, S.C.; Janicak, P.G.; Marks, R.C.; Davis, J.M. 1990: Platelet serotonin-2 receptor binding sites in depression and suicide. Biological Psychiatry 28(3): 215-222
Amstein, R.; Fetkovska, N.; Bühler, F.R. 1991: Platelet serotonin-LDL interaction in essential hypertension. Journal of Cardiovascular Pharmacology 17(Suppl 5): S35-S40
Goodman, S.L.; Grasel, T.G.; Cooper, S.L.; Albrecht, R.M. 1989: Platelet shape change and cytoskeletal reorganization on polyurethaneureas. Journal of Biomedical Materials Research 23(1): 105-123
Hattori, A.; Sanada, M.; Kojima, T.; Ihzumi, T.; Shibata, A. 1979: Platelet shape in various clinical conditions. its relation to the disease and significance. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(3): 558-559
Siess, W.; Grünberg, B.; Luber, K.; Vauti, F.; Wilhelm, B. 1992: Platelet signal transduction mechanisms induced by eicosanoids. Eicosanoids 5 Suppl: S13-S15
Kakishita, E. 1987: Platelet size. Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 71: 217-228
Wong, T.; Pedvis, L.; Frojmovic, M. 1989: Platelet size affects both micro- and macro-aggregation: contributions of platelet number, volume fraction and cell surface. Thrombosis and Haemostasis 62(2): 733-741
Milton, J.G.; Hutton, R.A.; Tuddenham, E.G.; Frojmovic, M.M. 1985: Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities. Journal of Laboratory and Clinical Medicine 106(3): 326-335
Kelemen, E. 1977: Platelet size and thrombocytopoietic stimulus in man. British Journal of Haematology 36(3): 449-450
Thomas, P.R. 1992: Platelet size and venous disease. Lancet 339(8787): 250-251
Mayer, M.; Dolfen, P.; Schaefer, J.; Queisser, W. 1978: Platelet size distribution in mice following immunothrombopenia and vincristine administration. Blut 36(3): 159-169
Bergström, B.; Mattiasson, I.; Rosén, I.; Lilja, B.; Sundkvist, G.; Mattiasso, I. 1989: Platelet sodium and potassium ATPase [corrected] activity and noradrenaline efflux rate in relation to autonomic and peripheral nerve function in insulin-dependent diabetic patients. Journal of Internal Medicine 225(3): 185-190
Berntorp, K.; Lindgärde, F.; Mattiasson, I. 1987: Platelet sodium kinetics, blood pressure and serum urate: aberrations in non-obese men at risk for type 2 diabetes mellitus. Clinical Science 73(1): 109-116
Schmouder, R.L.; Weder, A.B. 1989: Platelet sodium-proton exchange is increased in essential hypertension. Journal of Hypertension 7(4): 325-330
Salles, J.P.; Barthe, P.; Begasse, F.; Bouissou, F.; Chap, H.; Chamontin, B. 1991: Platelet sodium-proton exchange rates in young adults with a history of childhood hypertension. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 9(6): S316-S317
Smith, J.W.; Kelton, J.G.; Horsewood, P.; Brown, C.; Giles, A.; Meyer, R.; Woods, V.; Burrows, R. 1989: Platelet specific alloantigens on the platelet glycoprotein Ia/IIa complex. British Journal of Haematology 72(4): 534-538
Rhys Davies, E. 1990: Platelet specific monoclonal antibody. British Journal of Radiology 63(750): 501
Csaicsich, P.; Deutinger, J.; Tatra, G. 1989: Platelet specific proteins (beta-thromboglobulin and platelet factor 4) in normal pregnancy and in pregnancy complicated by preeclampsia. Archives of Gynecology and Obstetrics 244(2): 91-95
Savolainen, S.; Liewendahl, K.; Syrjälä, M.T.; Gripenberg, J. 1992: Platelet splenic transit times in idiopathic thrombocytopenic purpura. Compartmental vs. non-compartmental model. International Journal of Hematology 55(1): 81-87
Syrbe, G.; Jütte, A.; Jorke, D. 1988: Platelet spreading in diabetes mellitus. Folia Haematologica 115(6): 935-944
Martin, B.M.; Feinman, R.D.; Detwiler, T.C. 1975: Platelet stimulation by thrombin and other proteases. Biochemistry 14(6): 1308-1314
Korc-Grodzicki, B.; Tauber-Finkelstein, M.; Shaltiel, S. 1988: Platelet stimulation releases a cAMP-dependent protein kinase that specifically phosphorylates a plasma protein. Proceedings of the National Academy of Sciences of the United States of America 85(20): 7541-7545
Banfi, G.; Bonini, P.A. 1988: Platelet storage and platelet volume. American Journal of Clinical Pathology 90(2): 230
Seghatchian, M.J. 1991: Platelet storage and transfusion. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(2): 355
Murphy, S.; Gardner, F.H. 1975: Platelet storage at 22 degrees C: role of gas transport across plastic containers in maintenance of viability. Blood 46(2): 209-218
McGill, M. 1978: Platelet storage by temperature cycling. Progress in Clinical and Biological Research 28: 119-139
Hogge, D.E.; Thompson, B.W.; Schiffer, C.A. 1986: Platelet storage for 7 days in second-generation blood bags. Transfusion 26(2): 131-135
Murphy, S. 1986: Platelet storage for transfusion. Beitrage Zu Infusionstherapie und Klinische Ernahrung 15: 93-106
Rock, G.; Swenson, S.D.; Adams, G.A. 1985: Platelet storage in a plasma-free medium. Transfusion 25(6): 551-556
Holme, S.; Heaton, W.A.; Courtright, M. 1987: Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sanguinis 53(4): 214-220
Holme, S.; Heaton, W.A.; Whitley, P. 1990: Platelet storage lesions in second-generation containers: correlation with in vivo behavior with storage up to 14 days. Vox Sanguinis 59(1): 12-18
Labow, R.S.; Tocchi, M.; Rock, G. 1986: Platelet storage. Effects of leachable materials on morphology and function. Transfusion 26(4): 351-357
Feinberg, H.; Sarin, M.M.; Batka, E.A.; Porter, C.R.; Miripol, J.E.; Stewart, M. 1988: Platelet storage: changes in cytosolic Ca2+ actin polymerization and shape. Blood 72(2): 766-769
White, J.G. 1987: Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis. Cardiovascular Clinics 18(1): 13-33
Suzuki, H.; Yamazaki, H.; Tanoue, K. 1992: Platelet structure and function: immunocytochemical localizations of membrane glycoprotein and alpha-granule protein. Nihon Rinsho. Japanese Journal of Clinical Medicine 50(2): 218-222
Rohn, R.J.; Campbell, R.L.; Clark, J.C. 1978: Platelet studies as a measure of coagulative integrity of the surgical patient. Journal of the Indiana State Medical Association 71(3): 325-328
Singer, C.R.; Walker, J.J.; Cameron, A.; Fraser, C. 1986: Platelet studies in normal pregnancy and pregnancy-induced hypertension. Clinical and Laboratory Haematology 8(1): 27-32
Burns, E.R. 1991: Platelet studies in the pathogenesis of thrombocytopenia in May-Hegglin anomaly. American Journal of Pediatric Hematology/Oncology 13(4): 431-436
Yamada, K.; Inagaki, M.; Fukumoto, T.; Meguro, T. 1979: Platelet studies in von Willebrand's disease, especially on the platelet adhesion to subendothelium and platelet binding with factor VIIi. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 864-871
Gmür, J.; Osterwalder, B.; Scall, G.; Metaxas, M.; von Felten, A. 1979: Platelet substitution with single donor thrombocytes versus thrombocyte concentrates: improvement of the transfusion success due to delayed sensitization. Schweizerische Medizinische Wochenschrift 109(37): 1395
Harding, S.A.; Shakoor, M.A.; Grindon, A.J. 1975: Platelet support for cardiopulmonary bypass surgery. Journal of Thoracic and Cardiovascular Surgery 70(2): 350-353
Theiss, W.; Blömer, H. 1979: Platelet suppressant therapy and oral anticoagulants in the secondary prevention of acute myocardial infarction (authors transl). Herz 4(5): 419-427
Ando, Y.; Watanabe, K.; Ikeda, Y. 1979: Platelet surface membranes in platelets with spontaneous aggregation. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(3): 562-563
Donnér, M.; Békássy, N.A.; Heldrup, J.; Wiebe, T.; Garwicz, S.; Holmberg, L. 1990: Platelet surface-bound IgG and platelet-specific IgG in plasma in childhood thrombocytopenia. Acta Paediatrica Scandinavica 79(3): 328-334
Court, W.S.; Bozeman, J.M.; Soong, S.J.; Saleh, M.N.; Shaw, D.R.; LoBuglio, A.F. 1987: Platelet surface-bound IgG in patients with immune and nonimmune thrombocytopenia. Blood 69(1): 278-283
Mustard, J.F. 1978: Platelet survival. Thrombosis and Haemostasis 40(1): 154-162
Uhlemann, E.R.; TenPas, J.H.; Lucky, A.W.; Schulman, J.D.; Mudd, S.H.; Shulman, N.R. 1976: Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency. New England Journal of Medicine 295(23): 1283-1286
Kutti, J.; Weinfeld, A. 1979: Platelet survival and platelet production in acute myocardial infarction. Acta Medica Scandinavica 205(6): 501-504
Clagett, G.P.; Hufnagel, H.; Watkins, M.T.; Sharefkin, J.B. 1987: Platelet survival and serotonin content after placement of arterial prostheses in dogs: effects of neointimal coverage and high- and low-dose aspirin. Journal of Vascular Surgery 6(6): 555-562
Kiefel, V.; Becker, T.; Mueller-Eckhardt, G.; Grebe, S.; Mueller-Eckhardt, C. 1985: Platelet survival determined with 51Cr versus 111in. Klinische Wochenschrift 63(2): 84-89
Scott, C.R. 1976: Platelet survival in homocystinuria. New England Journal of Medicine 295(21): 1200
Ritchie, J.L.; Cobb, L.A.; Harker, L.A. 1979: Platelet survival in patients previously resuscitated from out-of-hospital ventricular fibrillation. Journal of Laboratory and Clinical Medicine 93(2): 310-315
Eldor, A.; Krausz, Y.; Atlan, H.; Snyder, D.; Goldfarb, A.; Hy-Am, E.; Rachmilewitz, E.A.; Kotze, H.F.; Heyns, A.D. 1989: Platelet survival in patients with beta-thalassemia. American Journal of Hematology 32(2): 94-99
Okuma, M.; Yamori, Y. 1976: Platelet survival studies in stroke-prone spontaneously hypertensive rats (SHRSP). Stroke 7(1): 60-64
Steele, P.; Weily, H.; Rainwater, J.; Vogel, R. 1979: Platelet survival time and thromboembolism in patients with mitral valve prolapse. Circulation 60(1): 43-45
Wipf, R.; Stinghe, R. 1978: Platelet survival time in hypoxemic patients. American Review of Respiratory Disease 118(2): 447
Harker, L.A. 1978: Platelet survival time: its measurement and use. Progress in Hemostasis and Thrombosis 4: 321-347
Gallus, A.S.; Walker, I.R.; Hirsh, J.; Halasah, G.; Evans, G. 1975: Platelet survival, fibrinolytic activity, antithrombin Ii (AT III) level and fibrinogen survival in venous thromboembolism (VTE). Thrombosis et Diathesis Haemorrhagica 34(2): 566
Berild, D.; Hasselbalch, H.; Knudsen, J.B. 1987: Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders. Scandinavian Journal of Clinical and Laboratory Investigation 47(5): 497-501
Abbate, R.; Pinto, S.; Panetta, A.; Favilla, S.; Prisco, D.; Paniccia, R.; Vanni, D.; Gensini, G.F.; Neri Serneri, G.G. 1988: Platelet synthesis of cyclooxygenase and lipoxygenase products in type i and type Ii diabetes. Prostaglandins Leukotrienes and Essential Fatty Acids 31(1): 9-15
Filla, A.; Butterworth, R.F.; Geoffroy, G.; Lemieux, B.; Barbeau, A. 1978: Platelet taurine uptake in spinocerebellar degeneration. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 5(1): 119-123
Fujimaki, M.; Nagasawa, H.; Kagawa, K. 1988: Platelet tests and evaluation. Rinsho Byori. Japanese Journal of Clinical Pathology 36(5): 512-516
Sato, M.; Onohara, M.; Ookawa, K.; Ohshima, N. 1992: Platelet thrombi produced on cultured endothelial cells by the dye/light method. Biorheology 29(5-6): 489-498
Takamatsu, J. 1986: Platelet thrombin receptor. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(8): 1569-1576
Maccia, C.A.; Gallagher, J.S.; Ataman, G.; Glueck, H.I.; Brooks, S.M.; Bernstein, I.L. 1977: Platelet thrombopathy in asthmatic patients with elevated immunoglobulin e. Journal of Allergy and Clinical Immunology 59(2): 101-108
Legrand, C.; Bellucci, S.; Disdier, M.; Edelman, L.; Tobelem, G. 1991: Platelet thrombospondin and glycoprotein IV abnormalities in patients with essential thrombocythemia: effect of alpha-interferon treatment. American Journal of Hematology 38(4): 307-313
Silverstein, R.L.; Leung, L.L.; Harpel, P.C.; Nachman, R.L. 1985: Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. Journal of Clinical Investigation 75(6): 2065-2073
Ushikubi, F.; Hirata, M.; Narumiya, S.; Okuma, M. 1992: Platelet thromboxane A2 receptor. Nihon Rinsho. Japanese Journal of Clinical Medicine 50(2): 264-268
Modesti, P.A.; Abbate, R.; Gensini, G.F.; Colella, A.; Neri Serneri, G.G. 1989: Platelet thromboxane A2 receptors in habitual smokers. Thrombosis Research 55(2): 195-201
Modesti, P.A.; Abbate, R.; Gensini, G.F.; Colella, A.; Neri Serneri, G.G. 1991: Platelet thromboxane A2 receptors in type i diabetes. Clinical Science 80(2): 101-105
Jaschonek, K.; Faul, C.; Weisenberger, H.; Krönert, K.; Schröder, H.; Renn, W. 1989: Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type i diabetes mellitus. Thrombosis and Haemostasis 61(3): 535-536
Covatto, R.H.; Niewiarowski, S. 1990: Platelet thromboxane A2/prostaglandin H2 receptors in human volunteers on low doses of aspirin. Biochemical Pharmacology 40(7): 1559-1561
Kääpä, P. 1987: Platelet thromboxane B2 production in neonatal pulmonary hypertension. Archives of Disease in Childhood 62(2): 195-196
Davì, G.; Migneco, G.; Vigneri, S.; Tripi, S.; Scialabba, A.; Strano, A. 1985: Platelet thromboxane production in liver cirrhosis. Prostaglandins Leukotrienes and Medicine 19(1): 99-104
Takahashi, R.; Shiraki, M.; Morita, I.; Ito, H.; Murota, S.; Orimo, H. 1985: Platelet thromboxane synthesizing activity in non-insulin-dependent diabetes: correlation with diabetic retinopathy and diabetic treatment. Prostaglandins Leukotrienes and Medicine 17(2): 149-158
Sirchia, G. 1986: Platelet transfusion and HLA immunisation. Vox Sanguinis 51(1): 74
Amamiya, Y.; Hisamatsu, J.; Ito, T.; Baba, M.; Amaki, T. 1978: Platelet transfusion and isologous HLA. Japanese Journal of Clinical Hematology 19(10): 1422-1428
Yamaguchi, K.; Kawakatsu, T.; Kido, H.; Suzuki, M.; Fukuroi, T.; Yanabu, M.; Nomura, S.; Kokawa, T.; Yasunaga, K. 1992: Platelet transfusion for patients with Glanzmann's thromboasthenia. Vox Sanguinis 63(4): 290
Abrahm, J.; Ellman, L. 1976: Platelet transfusion in immune thrombocytopenic purpura. JAMA 236(16): 1847
Guarini, A.; Gugliotta, L.; Ledinek, M. 1978: Platelet transfusion in the peroperative care of hemopathic patients. Giornale di Clinica Medica 59(1-2): 34-42
Eastlund, D.T.; McGrath, P.C.; Burkart, P. 1988: Platelet transfusion reaction associated with interdonor HLA incompatibility. Vox Sanguinis 55(3): 157-160
Aisner, J. 1977: Platelet transfusion therapy. Medical Clinics of North America 61(5): 1133-1145
Schiffer, C.A.; Aisner, J.; Wiernik, P.H. 1978: Platelet transfusion therapy for patients with leukemia. Progress in Clinical and Biological Research 28: 267-279
Fuller, A.K. 1990: Platelet transfusion therapy for thrombocytopenia. Seminars in Oncology Nursing 6(2): 123-128
Charak, B.S.; Rao, K.; Parikh, P.M.; Rawat, R.S.; Nair, C.N.; Advani, S.H. 1989: Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies. Journal of the Association of Physicians of India 37(3): 201-203
Brand, A.; van Leeuwen, A.; Eernisse, J.G.; van Rood, J.J. 1978: Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood 51(5): 781-788
Blajchman, M.A.; Thornley, J.H.; Richardson, H.; Elder, D.; Spiak, C.; Racher, J. 1979: Platelet transfusion-induced Serratia marcescens sepsis due to vacuum tube contamination. Transfusion 19(1): 39-44
Herman, J.H.; Kamel, H.T. 1987: Platelet transfusion. Current techniques, remaining problems, and future prospects. American Journal of Pediatric Hematology/Oncology 9(3): 272-286
Kelton, J.G.; Blajchman, M.A. 1979: Platelet transfusions. Canadian Medical Association Journal 121(10): 1353-1358
Ahn, Y.S.; Harrington, W.J. 1975: Platelet transfusions in clinical medicine. Advances in Internal Medicine 20: 379-398
Tandy, N.P.; Pamphilon, D.H. 1991: Platelet transfusions irradiated with ultraviolet-B light may have a role in reducing recipient alloimmunization. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(2): 383-388
Murphy, M.F.; Waters, A.H. 1990: Platelet transfusions: applications and controversies. Journal of Clinical Apheresis 5(2): 83-86
Schneider, L.S.; Severson, J.A.; Chui, H.C.; Pollock, V.E.; Sloane, R.B.; Fredrickson, E.R. 1988: Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions. Psychiatry Research 25(3): 311-322
Côté, G.P.; Lewis, W.G.; Pato, M.D.; Smillie, L.B. 1978: Platelet tropomyosin: lack of binding to skeletal muscle troponin and correlation with sequence. Febs Letters 94(1): 131-135
Heyns, A.d.P.; Badenhorst, P.N.; Lötter, M.G.; Pieters, H.; Wessels, P.; Kotzé, H.F. 1986: Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood 67(1): 86-92
Burger, T.; Schnell, J.; Schmelczer, M. 1979: Platelet turnover and megakaryocytopoiesis in ITP. Acta Medica Academiae Scientiarum Hungaricae 36(1): 45-51
Rodvien, R.; Mitchell, R.R.; Dalal, K.B.; Bosak, J.; Baleix, J.; Litwak, P.; Hill, J.D. 1979: Platelet turnover studies associated with left ventricular assist device (LVAD) implantation. Transactions - American Society for Artificial Internal Organs 25: 118-123
Ferrell, J.E.; Martin, G.S. 1988: Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Molecular and Cellular Biology 8(9): 3603-3610
Wu, J.; Chen, K.J. 1988: Platelet ultrastructure and function of coronary heart disease in patients with the blood-stasis symptom-complex. Zhong Xi Yi Jie he Za Zhi 8(10): 593
White, J.G.; Gerrard, J.M. 1978: Platelet ultrastructure in relation to platelet function. Progress in Clinical and Biological Research 28: 5-23
Hallstrom, C.O.; Rees, W.L.; Pare, C.M.; Trenchard, A.; Turner, P. 1976: Platelet uptake of 5-hydroxytryptamine and dopamine in depression. Postgraduate Medical Journal 52(3 Suppl): 40-46
Boissier, J.R.; Godefroy, F.; Soubrie, P.; Thiebot, M.H.; Weil-Fugazza, J. 1976: Platelet uptake of [14C]-5-hydroxytryptamine in "emotional" and "non-emotional" rats. British Journal of Pharmacology 58(3): 454P-455P
Neiman, J.; Beving, H.; Malmgren, R. 1987: Platelet uptake of serotonin (5-HT) during ethanol withdrawal in male alcoholics. Thrombosis Research 46(6): 803-809
Inaba, K.; Umeda, Y.; Yamane, Y.; Urakami, M.; Nagata, T.; Inada, M. 1989: Platelet vasopressin receptor in patients with chronic renal failure. Nihon Jinzo Gakkai Shi 31(10): 1079-1084
Asijee, G.M.; Muszbek, L.; Kappelmayer, J.; Polgár, J.; Horváth, A.; Sturk, A. 1988: Platelet vinculin: a substrate of activated factor XIIi. Biochimica et Biophysica Acta 954(3): 303-308
Coller, B.S.; Cheresh, D.A.; Asch, E.; Seligsohn, U. 1991: Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 77(1): 75-83
O'Brien, J.R.; Jamieson, S. 1976: Platelet volume and aspirin-induced inhibition of aggregation. Blood 48(4): 623-624
Le Tohic, F.; Prost-Dvojakovic, R.J.; Le Menn, R.; Samama, M. 1978: Platelet volume in essential thrombopenia. Nouvelle Revue Francaise d'Hematologie 20(2): 155-171
Kishk, Y.T.; Trowbridge, E.A.; Martin, J.F. 1985: Platelet volume subpopulations in acute myocardial infarction: an investigation of their homogeneity for smoking, infarct size and site. Clinical Science 68(4): 419-425
Tohgi, H.; Suzuki, H.; Tamura, K.; Kimura, B. 1991: Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke 22(1): 17-21
Nouvel, C.; Caranobe, C.; Sie, P.; Capdeville, J.; Pris, J.; Boneu, B. 1978: Platelet volume, density and 5 HT organelles (mepacrine test) in acute leukaemia. Scandinavian Journal of Haematology 21(5): 421-426
Lande, K.; Os, I.; Kjeldsen, S.E.; Westheim, A.; Aakesson, I.; Hjermann, I.; Eide, I.; Gjesdal, K. 1986: Platelet volume, platelet release reaction and platelet response to infused adrenaline are increased in essential hypertension. Acta Medica Scandinavica. Supplementum 714: 129-132
Taniguchi, T.; Matsuo, N.; Ishikura, H.; Moriguchi, T.; Yamamoto, T.; Tanaka, T. 1989: Platelet volumetry and functional significance in septic rat: alterations in adenylate pool: preliminary report. Nihon Geka Gakkai Zasshi 90(2): 317
Rodeghiero, F.; Castaman, G.C.; Tosetto, A.; Lattuada, A.; Mannucci, P.M. 1990: Platelet von Willebrand factor assay: results using two methods for platelet lysis. Thrombosis Research 59(2): 259-267
Gralnick, H.R.; Rick, M.E.; McKeown, L.P.; Williams, S.B.; Parker, R.I.; Maisonneuve, P.; Jenneau, C.; Sultan, Y. 1986: Platelet von Willebrand factor: an important determinant of the bleeding time in type i von Willebrand's disease. Blood 68(1): 58-61
Gralnick, H.R.; Williams, S.B.; McKeown, L.P.; Krizek, D.M.; Shafer, B.C.; Rick, M.E. 1985: Platelet von Willebrand factor: comparison with plasma von Willebrand factor. Thrombosis Research 38(6): 623-633
Black, K.D.; Weiner, S. 1992: Platelet vulnerability in the fetus/neonate with neonatal alloimmune thrombocytopenia. Journal of Perinatal and Neonatal Nursing 6(3): 47-56
Holmberg, L.; Kristoffersson, A.C.; Lamme, S.; Nilsson, I.M.; Awidi, A.; Solum, N.O. 1985: Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease. Scandinavian Journal of Haematology 35(3): 305-314
Fetkovská, N.; Fedelesová, V.; Kozlovský, M.; Dzúrik, R. 1991: Platelet-activating effect of low-density lipoprotein and its reversal by isradipine. American Journal of Hypertension 4(2 Part 2): 175s-177s
Benveniste, J.; Camussi, J.; Polonsky, J. 1977: Platelet-activating factor. Monographs in Allergy 12: 138-142
Bazan, H.E.; Reddy, S.T.; Lin, N. 1991: Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Experimental Eye Research 52(4): 481-491
Tool, A.T.; Verhoeven, A.J.; Roos, D.; Koenderman, L. 1989: Platelet-activating factor (PAF) acts as an intercellular messenger in the changes of cytosolic free Ca2+ in human neutrophils induced by opsonized particles. Febs Letters 259(1): 209-212
Hosford, D.; Mencia-Huerta, J.M.; Braquet, P. 1990: Platelet-activating factor (PAF) and PAF antagonists in asthma. Critical Reviews in Therapeutic Drug Carrier Systems 7(3): 261-273
Peplow, P.V.; Mikhailidis, D.P. 1990: Platelet-activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolism. Prostaglandins Leukotrienes and Essential Fatty Acids 41(2): 71-82
Workman, P.; Donaldson, J.; Lohmeyer, M. 1991: Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRi 62-834 in HL-60 promyelocytic leukaemia cells. Biochemical Pharmacology 41(2): 319-322
Tsao, P.S.; Stahl, G.A.; Lefer, A.M.; Salvino, J.; Pietranico, S.; Nicolaou, K.C. 1989: Platelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofurans. Journal of Lipid Mediators 1(3): 189-199
Terasawa, M. 1991: Platelet-activating factor (PAF) antagonists. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 36(3): 379-387
Edwards, R.M.; Trizna, W.; Feuerstein, G. 1991: Platelet-activating factor (PAF) has no direct effect on rat intracerebral arterioles in vitro. Journal of Lipid Mediators 3(2): 161-165
Nakamura, T.; Kuriyama, M.; Ishihara, K.; Matsumura, Y.; Miyamoto, T. 1991: Platelet-activating factor (PAF) in allergic diseases: inhibitory effects of anti-allergic drugs, ketotifen and three kampo medicines on PAF production. Lipids 26(12): 1297-1300
Soloviev, A.I.; Braquet, P. 1991: Platelet-activating factor (PAF) induces contraction of saponin-skinned smooth muscle of coronary artery. Lipids 26(12): 1274-1276
Ostermann, G.; Hofmann, B.; Kertscher, H.P.; Till, U. 1990: Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 342(6): 713-718
Doebber, T.W.; Wu, M.S.; Biftu, T. 1986: Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. Journal of Immunology 136(12): 4659-4668
Morooka, S.; Uchida, M.; Imanishi, N. 1992: Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine. British Journal of Pharmacology 105(3): 756-762
Ammit, A.J.; O'Neill, C. 1991: Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood. Lipids 26(12): 1189-1192
Patrignani, P.; Valitutti, S.; Aiello, F.; Musiani, P. 1987: Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation. Biochemical and Biophysical Research Communications 148(2): 802-810
Bito, H.; Nakamura, M.; Honda, Z.; Izumi, T.; Iwatsubo, T.; Seyama, Y.; Ogura, A.; Kudo, Y.; Shimizu, T. 1992: Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons. Neuron 9(2): 285-294
Yue, T.L.; Gleason, M.M.; Gu, J.L.; Lysko, P.G.; Hallenbeck, J.; Feuerstein, G. 1991: Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist. Journal of Pharmacology and Experimental Therapeutics 257(1): 374-381
Ng, D.S.; Wong, K. 1989: Platelet-activating factor (PAF) stimulates phosphatidylinositol hydrolysis in human peripheral blood mononuclear leukocytes. Research Communications in Chemical Pathology and Pharmacology 66(2): 219-231
Doebber, T.W.; Wu, M.S. 1987: Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils. Proceedings of the National Academy of Sciences of the United States of America 84(21): 7557-7561
Doebber, T.W.; Wu, M.S.; Mauriello, A.; Alberts, A. 1991: Platelet-activating factor (PAF) stimulates the lysoPAF acetyltransferase in leukocyte-rich plasma: use in PAF antagonist studies. Lipids 26(12): 997-1003
Satoh, K.; Imaizumi, T.; Kawamura, Y.; Yoshida, H.; Hiramoto, M.; Takamatsu, S.; Takamatsu, M. 1991: Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2. Journal of Clinical Investigation 87(2): 476-481
Yue, T.L.; Rabinovici, R.; Feuerstein, G. 1991: Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury. Advances in Experimental Medicine and Biology 314: 223-233
Block, L.H.; Abraham, W.M.; Groscurth, P.; Qiao, B.Y.; Perruchoud, A.P. 1989: Platelet-activating factor (PAF)-dependent biochemical, morphologic, and physiologic responses of human platelets: demonstration of translocation of protein kinase C associated with protein phosphorylation. American Journal of Respiratory Cell and Molecular Biology 1(4): 277-288
Fukuda, T.; Numao, T.; Akutsu, I.; Makino, S. 1992: Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils. Journal of Lipid Mediators 5(2): 145-149
Misawa, M.; Iwamura, S. 1990: Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs. Japanese Journal of Pharmacology 54(2): 217-226
Nojima, S. 1991: Platelet-activating factor (PAF): an introduction. Lipids 26(12): 965-966
Lagente, V.; Fortes, Z.B.; Garcia-Leme, J.; Vargaftig, B.B. 1987: Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists. Brazilian Journal of Medical and Biological Research 20(5): 595-597
Hirafuji, M.; Nave, J.F. 1987: Platelet-activating factor (PAF-acether) formation in rat basophilic leukemia cells stimulated by ionophore A23187. Agents and Actions 22(1-2): 159-164
Bruynzeel, P.L.; Koenderman, L.; Kok, P.T.; Hameling, M.L.; Verhagen, J. 1986: Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils. Pharmacological Research Communications 18 Suppl: 61-69
Kloprogge, E.; Akkerman, J.W. 1986: Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms. Biochemical Journal 240(2): 403-412
Stanton, A.W.; Izumi, T.; Antoniw, J.W.; Piper, P.J. 1989: Platelet-activating factor (Paf) antagonist, WEB 2086, protects against Paf-induced hypotension in Macaca fascicularis. British Journal of Pharmacology 97(3): 643-646
Stafforini, D.M.; Prescott, S.M.; Zimmerman, G.A.; McIntyre, T.M. 1991: Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids 26(12): 979-985
Maki, N.; Hoffman, D.R.; Johnston, J.M. 1988: Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Proceedings of the National Academy of Sciences of the United States of America 85(3): 728-732
Yoshida, H.; Satoh, K.; Imaizumi, T.; Takamatsu, S.; Hiramoto, M.; Shoji, B.; Takamatsu, M. 1992: Platelet-activating factor acetylhydrolase activity in red blood cell-stroma from patients with cerebral thrombosis. Acta Neurologica Scandinavica 86(2): 199-203
Stafforini, D.M.; McIntyre, T.M.; Prescott, S.M. 1990: Platelet-activating factor acetylhydrolase from human plasma. Methods in Enzymology 187: 344-357
Stafforini, D.M.; Prescott, S.M.; McIntyre, T.M. 1991: Platelet-activating factor acetylhydrolase in human erythrocytes. Methods in Enzymology 197: 411-425
Satoh, K.; Imaizumi, T.; Yoshida, H.; Kawamura, Y.; Takamatsu, S.; Takamatsu, M.; Mizuno, S. 1991: Platelet-activating factor acetylhydrolase in plasma lipoproteins of healthy men and women. Clinica Chimica Acta; International Journal of Clinical Chemistry 202(1-2): 95-103
Elstad, M.R.; Stafforini, D.M.; McIntyre, T.M.; Prescott, S.M.; Zimmerman, G.A. 1989: Platelet-activating factor acetylhydrolase increases during macrophage differentiation. a novel mechanism that regulates accumulation of platelet-activating factor. Journal of Biological Chemistry 264(15): 8467-8470
Squinto, S.P.; Braquet, P.; Block, A.L.; Bazan, N.G. 1990: Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes. Journal of Molecular Neuroscience: Mn 2(2): 79-84
Nakajima, T.; Sugimoto, T.; Kurachi, Y. 1991: Platelet-activating factor activates cardiac GK via arachidonic acid metabolites. Febs Letters 289(2): 239-243
Yang, J.P.; Tashjian, A.H. 1991: Platelet-activating factor affects cytosolic free calcium concentration and prolactin secretion in GH4C1 rat pituitary cells. Biochemical and Biophysical Research Communications 174(2): 424-431
Perico, N.; Remuzzi, A.; Dadan, J.; Battaglia, C.; Remuzzi, G. 1991: Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats. American Journal of Physiology 261(1 Part 2): F85-F90
Paubert-Braquet, M.; Koltz, P.; Guilbaud, J.; Hosford, D.; Braquet, P. 1990: Platelet-activating factor amplifies tumour necrosis factor-induced superoxide generation by human neutrophils. Advances in Experimental Medicine and Biology 264: 275-282
Anderson, R.C.; Reitter, B.E.; Winslow, C.M. 1986: Platelet-activating factor analogs. II. Synthesis of the 1-O-(4-decyloxymethylphenyl)- and 1-O-(4-decyloxyphenylmethyl) analogs. Chemistry and Physics of Lipids 39(1-2): 73-82
Townley, R.G.; Hopp, R.J.; Agrawal, D.K.; Bewtra, A.K. 1989: Platelet-activating factor and airway reactivity. Journal of Allergy and Clinical Immunology 83(6): 997-1010
Masugi, F.; Ogihara, T.; Saeki, S.; Sakaguchi, K.; Kumahara, Y. 1988: Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. Journal of Human Hypertension 2(2): 111-116
Barnes, P.J. 1988: Platelet-activating factor and asthma. Journal of Allergy and Clinical Immunology 81(1): 152-160
Hosford, D.; Paubert-Braquet, M.; Braquet, P. 1989: Platelet-activating factor and cytokine interactions in shock. Resuscitation 18(2-3): 207-218
Makino, S. 1989: Platelet-activating factor and disease. Kokyu to Junkan. Respiration and Circulation 37(2): 118-126
Suematsu, M.; Tsuchiya, M. 1991: Platelet-activating factor and granulocyte-mediated oxidative stress. Strategy for in vivo oxyradical visualization. Lipids 26(12): 1362-1368
Makowka, L.; Chapman, F.A.; Cramer, D.V.; Qian, S.G.; Sun, H.; Starzl, T.E. 1990: Platelet-activating factor and hyperacute rejection. the effect of a platelet-activating factor antagonist, SRi 63-441, on rejection of xenografts and allografts in sensitized hosts. Transplantation 50(3): 359-365
Stenson, W.F. 1988: Platelet-activating factor and inflammatory bowel disease. Gastroenterology 95(5): 1416-1419
Evans, R.D.; Lund, P.; Williamson, D.H. 1991: Platelet-activating factor and its metabolic effects. Prostaglandins Leukotrienes and Essential Fatty Acids 44(1): 1-10
Verbey, N.L.; Van Delft, J.L.; Van Haeringen, N.J.; Braquet, P. 1989: Platelet-activating factor and laser trauma of the iris. Investigative Ophthalmology and Visual Science 30(6): 1101-1103
Fradin, A.; Zirrolli, J.A.; Maclouf, J.; Vausbinder, L.; Henson, P.M.; Murphy, R.C. 1989: Platelet-activating factor and leukotriene biosynthesis in whole blood. a model for the study of transcellular arachidonate metabolism. Journal of Immunology 143(11): 3680-3685
Ramesha, C.S.; Pickett, W.C. 1986: Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. Journal of Biological Chemistry 261(17): 7592-7595
Mencia-Huerta, J.M.; Benveniste, J. 1979: Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. European Journal of Immunology 9(5): 409-415
Frerichs, K.U.; Lindsberg, P.J.; Hallenbeck, J.M.; Feuerstein, G.Z. 1990: Platelet-activating factor and progressive brain damage following focal brain injury. Journal of Neurosurgery 73(2): 223-233
Joseph, R.; Welch, K.M.; D'Andrea, G.; Riddle, J.M. 1989: Platelet-activating factor and red blood cells. Thrombosis Research 53(6): 629-633
Snyder, F.; Lee, T.C.; Blank, M.L. 1989: Platelet-activating factor and related ether lipid mediators. Biological activities, metabolism, and regulation. Annals of the new York Academy of Sciences 568: 35-43
Feuerstein, G.; Siren, A.L. 1988: Platelet-activating factor and shock. Progress in Biochemical Pharmacology 22: 181-190
Stewart, A.G.; Piper, P.J. 1988: Platelet-activating factor and the cardiovascular system: involvement in cardiac anaphylaxis. Progress in Biochemical Pharmacology 22: 132-140
Jackson, C.V.; Schumacher, W.A.; Kunkel, S.L.; Driscoll, E.M.; Lucchesi, B.R. 1986: Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine. Circulation Research 58(2): 218-229
Birkle, D.L.; Kurian, P.; Braquet, P.; Bazan, N.G. 1988: Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. Journal of Neurochemistry 51(6): 1900-1905
Pirotzky, E.; Guilmard, C.; Sidoti, C.; Ivanow, F.; Principe, P.; Braquet, P. 1990: Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat. Renal Failure 12(3): 171-176
Wang, Y.Y.; Li, C.L. 1992: Platelet-activating factor antagonists and asthma. Sheng Li Ke Xue Jin Zhan 23(2): 136-140
Kochanek, P.; Schoettle, R.; Uhl, M.; Magargee, M.J.; Nemoto, E. 1991: Platelet-activating factor antagonists do not attenuate delayed posttraumatic cerebral edema in rats. Journal of Neurotrauma 8(1): 19-25
Vela, L.; García Merino, A.; Fernández-Gallardo, S.; Sánchez Crespo, M.; López Lozano, J.J.; Saus, C. 1991: Platelet-activating factor antagonists do not protect against the development of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 33(1): 81-86
Muacevic, G.; Heuer, H.O. 1992: Platelet-activating factor antagonists in experimental shock. Arzneimittel-Forschung 42(8): 1001-1004
Haynes, J.; Chang, S.W.; Morris, K.G.; Voelkel, N.F. 1988: Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs. Journal of Applied Physiology 65(5): 1921-1928
López-Farré, A.; Bernabeu, F.; Gómez-Garre, D.; Ramon y Cajal, S.; Braquet, P.; López-Novoa, J.M. 1990: Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats. Journal of Pharmacology and Experimental Therapeutics 253(1): 328-333
Barnes, P.J.; Chung, K.F.; Page, C.P. 1988: Platelet-activating factor as a mediator of allergic disease. Journal of Allergy and Clinical Immunology 81(5 Pt 1): 919-934
Wasserman, S.I. 1988: Platelet-activating factor as a mediator of bronchial asthma. Hospital Practice 23(11): 49-58
Dewald, B.; Baggiolini, M. 1986: Platelet-activating factor as a stimulus of exocytosis in human neutrophils. Biochimica et Biophysica Acta 888(1): 42-48
Boruff, J.S.; Karistad, M.D. 1991: Platelet-activating factor attenuates muscle amino acid. Journal of the Tennessee Medical Association 84(11): 548
Kraut, J.A.; Mishler, D.R.; Aboolian, A.; Nagami, G.T. 1992: Platelet-activating factor attenuates the arginine vasopressin-induced fall of transepithelial resistance across inner medullary collecting duct monolayers. Mineral and Electrolyte Metabolism 18(1): 9-14
Maier, R.V.; Hahnel, G.B.; Fletcher, J.R. 1992: Platelet-activating factor augments tumor necrosis factor and procoagulant activity. Journal of Surgical Research 52(3): 258-264
Valone, F.H. 1988: Platelet-activating factor binding and metabolism during human platelet aggregation. Thrombosis Research 50(1): 103-112
Valone, F.H.; Ruis, N.M. 1986: Platelet-activating factor binding to human platelet membranes. Biotechnology and Applied Biochemistry 8(5): 465-470
Biancone, L.; Tetta, C.; Turello, E.; Montrucchio, G.; Iorio, E.L.; Servillo, L.; Balestrieri, C.; Camussi, G. 1992: Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors. Journal of the American Society of Nephrology: Jasn 2(7): 1251-1261
Shalit, M.; Dabiri, G.A.; Southwick, F.S. 1987: Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly. Blood 70(6): 1921-1927
Woodward, D.F.; Spada, C.S.; Nieves, A.L.; Hawley, S.B.; Williams, L.S. 1989: Platelet-activating factor causes goblet cell depletion in the conjunctiva. European Journal of Pharmacology 168(1): 23-30
Lien, D.C.; Worthen, G.S.; Henson, P.M.; Bethel, R.A. 1992: Platelet-activating factor causes neutrophil accumulation and neutrophil-mediated increased vascular permeability in canine trachea. American Review of Respiratory Disease 145(3): 693-700
McMurtry, I.F.; Morris, K.G. 1986: Platelet-activating factor causes pulmonary vasodilation in the rat. American Review of Respiratory Disease 134(4): 757-762
Tetta, C.; Montrucchio, G.; Alloatti, G.; Roffinello, C.; Emanuelli, G.; Benedetto, C.; Camussi, G.; Massobrio, M. 1986: Platelet-activating factor contracts human myometrium in vitro. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 183(3): 376-381
Horii, T.; Okazaki, H.; Kino, M.; Kobayashi, Y.; Satouchi, K.; Saito, K. 1991: Platelet-activating factor detected in bronchoalveolar lavage fluids from an asthmatic patient. Lipids 26(12): 1292-1296
Gebremichael, I.; Leuenberger, P. 1992: Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects. Respiration; International Review of Thoracic Diseases 59(4): 193-196
Grigorian, G.Y.; Ryan, U.S. 1987: Platelet-activating factor effects on bovine pulmonary artery endothelial cells. Circulation Research 61(3): 389-395
Mazer, B.; Clay, K.L.; Renz, H.; Gelfand, E.W. 1990: Platelet-activating factor enhances Ig production in B lymphoblastoid cell lines. Journal of Immunology 145(8): 2602-2607
Bussolino, F.; Fischer, E.; Turrini, F.; Kazatchkine, M.D.; Arese, P. 1989: Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1). Journal of Biological Chemistry 264(36): 21711-21719
Nieminen, M.M.; Moilanen, E.K.; Nyholm J-E; Koskinen, M.O.; Karvonen, J.I.; Metsä-Ketelä, T.J.; Vapaatalo, H. 1991: Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man. European Respiratory Journal 4(5): 551-560
Nakamura, T.; Ishihara, K.; Kuriyama, M.; Ito, K.; Matsumura, Y. 1992: Platelet-activating factor in Japanese cedar pollinosis. Journal of Lipid Mediators 5(2): 193-195
Stenton, S.C.; Court, E.N.; Kingston, W.P.; Goadby, P.; Kelly, C.A.; Duddridge, M.; Ward, C.; Hendrick, D.J.; Walters, E.H. 1990: Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. European Respiratory Journal 3(4): 408-413
Matsumoto, K.; Taki, F.; Kondoh, Y.; Taniguchi, H.; Takagi, K. 1992: Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clinical and Experimental Pharmacology and Physiology 19(7): 509-515
Scappaticci, E.; Libertucci, D.; Bottomicca, F.; Da Col, R.; Silvestro, L.; Tetta, C.; Camussi, G. 1992: Platelet-activating factor in bronchoalveolar lavage from patients with sarcoidosis. American Review of Respiratory Disease 146(2): 433-438
Rabinovici, R.; Yue, T.L.; Feuerstein, G. 1991: Platelet-activating factor in cardiovascular stress situations. Lipids 26(12): 1257-1263
Camussi, G.; Salvidio, G. 1988: Platelet-activating factor in graft rejection. Progress in Biochemical Pharmacology 22: 106-117
Alecozay, A.A.; Casslén, B.G.; Riehl, R.M.; Deleon, F.D.; Harper, M.J.; Silva, M.; Nouchi, T.A.; Hanahan, D.J. 1989: Platelet-activating factor in human luteal phase endometrium. Biology of Reproduction 41(4): 578-586
Chung, K.F. 1992: Platelet-activating factor in inflammation and pulmonary disorders. Clinical Science 83(2): 127-138
Nakamura, T.; Morita, Y.; Kuriyama, M.; Ishihara, K.; Ito, K.; Miyamoto, T. 1987: Platelet-activating factor in late asthmatic response. International Archives of Allergy and Applied Immunology 82(1): 57-61
Yasuda, K.; Satouchi, K.; Saito, K. 1986: Platelet-activating factor in normal rat uterus. Biochemical and Biophysical Research Communications 138(3): 1231-1236
Foegh, M.L.; Chambers, E.; Khirabadi, B.S.; Nakanishi, T.; Ramwell, P.W. 1989: Platelet-activating factor in organ transplant rejection. Advances in Prostaglandin Thromboxane and Leukotriene Research 19: 377-382
Byrne, K.; Sessler, C.N.; Carey, P.D.; Sielaff, T.D.; Vasquez, A.; Tatum, J.L.; Hirsch, J.I.; Sugerman, H.J. 1991: Platelet-activating factor in porcine Pseudomonas acute lung injury. Journal of Surgical Research 50(2): 111-118
Camussi, G.; Salvidio, G.; Tetta, C. 1989: Platelet-activating factor in renal diseases. American Journal of Nephrology 9(Suppl): 23-26
Lindsberg, P.J.; Hallenbeck, J.M.; Feuerstein, G. 1991: Platelet-activating factor in stroke and brain injury. Annals of Neurology 30(2): 117-129
Watanabe, M.; Ohuchi, K.; Sugidachi, A.; Hirasawa, N.; Hayashi, Y.; Tsurufuji, S. 1987: Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats. International Archives of Allergy and Applied Immunology 84(4): 396-403
Angle, M.J.; Jones, M.A.; McManus, L.M.; Pinckard, R.N.; Harper, M.J. 1988: Platelet-activating factor in the rabbit uterus during early pregnancy. Journal of Reproduction and Fertility 83(2): 711-722
Kentroti, S.; Baker, R.; Lee, K.; Bruce, C.; Vernadakis, A. 1991: Platelet-activating factor increases glutamine synthetase activity in early and late passage C-6 glioma cells. Journal of Neuroscience Research 28(4): 497-506
Fisher, R.A.; Sharma, R.V.; Bhalla, R.C. 1989: Platelet-activating factor increases inositol phosphate production and cytosolic free Ca2+ concentrations in cultured rat Kupffer cells. Febs Letters 251(1-2): 22-26
Burhop, K.E.; Garcia, J.G.; Selig, W.M.; Lo, S.K.; van der Zee, H.; Kaplan, J.E.; Malik, A.B. 1986: Platelet-activating factor increases lung vascular permeability to protein. Journal of Applied Physiology 61(6): 2210-2217
Sasaki, T.; Shimura, S.; Ikeda, K.; Sasaki, H.; Takishima, T. 1989: Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland. American Journal of Physiology 257(6 Part 1): L373-L378
Mazer, B.; Domenico, J.; Sawami, H.; Gelfand, E.W. 1991: Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B lymphoblastoid cells. Journal of Immunology 146(6): 1914-1920
Kroegel, C.; Yukawa, T.; Dent, G.; Chanez, P.; Chung, K.F.; Barnes, P.J. 1988: Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils. Immunology 64(3): 559-561
Schiffrin, E.J.; Trop, M.; Schroeder, S.; Carter, E.A. 1991: Platelet-activating factor induces intestinal necrosis, but not septic shock, in germ-free and specific-pathogen-free rodents. Burns: Journal of the International Society for Burn Injuries 17(4): 276-278
Bruijnzeel, P.L.; Kok, P.T.; Hamelink, M.L.; Kijne, A.M.; Verhagen, J. 1987: Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils. Prostaglandins 34(2): 205-214
Brunner, T.; de Weck, A.L.; Dahinden, C.A. 1991: Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5. Journal of Immunology 147(1): 237-242
Agrawal, D.K.; Bergren, D.R.; Byorth, P.J.; Townley, R.G. 1991: Platelet-activating factor induces nonspecific desensitization to bronchodilators in guinea pigs. Journal of Pharmacology and Experimental Therapeutics 259(1): 1-7
Schulam, P.G.; Kuruvilla, A.; Putcha, G.; Mangus, L.; Franklin-Johnson, J.; Shearer, W.T. 1991: Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line. Journal of Immunology 146(5): 1642-1648
Gay, J.C.; Stitt, E.S. 1988: Platelet-activating factor induces protein kinase activity in the particulate fraction of human neutrophils. Blood 71(1): 159-165
Fauler, J.; Sielhorst, G.; Frölich, J.C. 1989: Platelet-activating factor induces the production of leukotrienes by human monocytes. Biochimica et Biophysica Acta 1013(1): 80-85
Gomez-Cambronero, J.; Wang, E.; Johnson, G.; Huang, C.K.; Sha'afi, R.I. 1991: Platelet-activating factor induces tyrosine phosphorylation in human neutrophils. Journal of Biological Chemistry 266(10): 6240-6245
Weisman, S.M.; Felsen, D.; Vaughan, E.D. 1985: Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. Journal of Pharmacology and Experimental Therapeutics 235(1): 10-15
Handa, R.K.; Strandhoy, J.W.; Buckalew, V.M. 1990: Platelet-activating factor is a renal vasodilator in the anesthetized rat. American Journal of Physiology 258(6 Part 2): F1504-F1509
Hanahan, D.J.; Weintraub, S.T. 1985: Platelet-activating factor isolation, identification, and assay. Methods of Biochemical Analysis 31: 195-219
López Bernal, A.; Newman, G.E.; Phizackerley, P.J.; Laird, E.; Ross, C.; Barlow, D.H. 1992: Platelet-activating factor levels in human follicular and amniotic fluids. European Journal of Obstetrics Gynecology and Reproductive Biology 46(1): 39-44
Filep, J.; Hermán, F.; Braquet, P. 1991: Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat. Lipids 26(12): 1356-1358
Stewart, A.G.; Harris, T. 1991: Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes. Lipids 26(12): 1044-1049
Lad, P.M.; Olson, C.V.; Grewal, I.S. 1985: Platelet-activating factor mediated effects on human neutrophil function are inhibited by pertussis toxin. Biochemical and Biophysical Research Communications 129(3): 632-638
Wang, J.; Dunn, M.J. 1987: Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. American Journal of Physiology 253(6 Part 2): F1283-F1289
Wallace, J.L.; Hogaboam, C.M.; McKnight, G.W. 1990: Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. American Journal of Physiology 259(1 Part 1): G140-G146
López-Farré, A.; Gómez-Garre, D.; Bernabeu, F.; Ramón y Cajal, S.; Perez-Rodrigo, P.; Braquet, P.; López-Novoa, J.M. 1990: Platelet-activating factor mediates glycerol-induced acute renal failure in rats. Clinical Science 79(6): 551-558
Chang, S.W.; Feddersen, C.O.; Henson, P.M.; Voelkel, N.F. 1987: Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. Journal of Clinical Investigation 79(5): 1498-1509
Ahmed, A.; Ferriani, R.A.; Plevin, R.; Smith, S.K. 1992: Platelet-activating factor mediates phosphatidylcholine hydrolysis by phospholipase D in human endometrium. Biology of Reproduction 47(1): 59-65
Billah, M.M.; Di Renzo, G.C.; Ban, C.; Truong, C.T.; Hoffman, D.R.; Anceschi, M.M.; Bleasdale, J.E.; Johnston, J.M. 1985: Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. Prostaglandins 30(5): 841-850
Doyle, V.M.; Creba, J.A.; Rüegg, U.T. 1986: Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells. Febs Letters 197(1-2): 13-16
Kucey, D.S.; Cheung, P.Y.; Rotstein, O.D. 1992: Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism. Infection and Immunity 60(3): 944-950
Braquet, P.; Pignol, B.; Maisonnet, T.; Mencia-Huerta, J.M. 1991: Platelet-activating factor modulates interleukin-6 production by mouse fibroblasts. International Archives of Allergy and Applied Immunology 94(1-4): 165-166
Tou, J.S. 1987: Platelet-activating factor modulates phospholipid acylation in human neutrophils. Lipids 22(5): 333-337
Ferguson-Chanowitz, K.M.; Katocs, A.S.; Pickett, W.C.; Kaplan, J.B.; Sass, P.M.; Oronsky, A.L.; Kerwar, S.S. 1990: Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin. Journal of Infectious Diseases 162(5): 1081-1086
Pignol, B.; Lonchampt, M.O.; Chabrier, P.E.; Mencia-Huerta, J.M.; Braquet, P. 1990: Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide. Journal of Lipid Mediators 2 Suppl: S83-S91
Kucey, D.S.; Kubicki, E.I.; Rotstein, O.D. 1991: Platelet-activating factor primes endotoxin-stimulated macrophage procoagulant activity. Journal of Surgical Research 50(5): 436-441
Zoratti, E.M.; Sedgwick, J.B.; Bates, M.E.; Vrtis, R.F.; Geiger, K.; Busse, W.W. 1992: Platelet-activating factor primes human eosinophil generation of superoxide. American Journal of Respiratory Cell and Molecular Biology 6(1): 100-106
Vercellotti, G.M.; Yin, H.Q.; Gustafson, K.S.; Nelson, R.D.; Jacob, H.S. 1988: Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 71(4): 1100-1107
Sun, X.M.; Hsueh, W. 1991: Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. Journal of Immunology 147(2): 509-514
Oda, M.; Satouchi, K.; Saito, K.; Ikeda, I. 1989: Platelet-activating factor producing cell--target cell interactions. Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 81: 9-15
Cristol, J.P.; Canaud, B.; Damon, M.; Chavis, C.; Arnoux, B.; Mion, C. 1992: Platelet-activating factor production during hemodialysis: effect of BN 52021. Prostaglandins Leukotrienes and Essential Fatty Acids 45(1): 37-42
Bussolino, F.; Torelli, S.; Stefanini, E.; Gremo, F. 1989: Platelet-activating factor production occurs through stimulation of cholinergic and dopaminergic receptors in the chick retina. Journal of Lipid Mediators 1(5): 283-288
Tou, J. 1985: Platelet-activating factor promotes arachidonate incorporation into phosphatidylinositol and phosphatidylcholine in neutrophils. Biochemical and Biophysical Research Communications 127(3): 1045-1051
Adler, K.B.; Akley, N.J.; Glasgow, W.C. 1992: Platelet-activating factor provokes release of mucin-like glycoproteins from guinea pig respiratory epithelial cells via a lipoxygenase-dependent mechanism. American Journal of Respiratory Cell and Molecular Biology 6(5): 550-556
Morigi, M.; Macconi, D.; Riccardi, E.; Boccardo, P.; Zilio, P.; Bertani, T.; Remuzzi, G. 1991: Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice. Journal of Pharmacology and Experimental Therapeutics 258(2): 601-606
Faden, A.I.; Halt, P. 1992: Platelet-activating factor reduces spinal cord blood flow and causes behavioral deficits after intrathecal administration in rats through a specific receptor mechanism. Journal of Pharmacology and Experimental Therapeutics 261(3): 1064-1070
Tou, J.S. 1989: Platelet-activating factor regulates phospholipid metabolism in human neutrophils. Lipids 24(9): 812-817
Webber, S.E.; Morikawa, T.; Widdicombe, J.G. 1992: Platelet-activating factor relaxes ferret tracheal smooth muscle and reduces transepithelial potential difference in vitro. British Journal of Pharmacology 105(1): 223-229
Squinto, S.P.; Block, A.L.; Braquet, P.; Bazan, N.G. 1989: Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells. Journal of Neuroscience Research 24(4): 558-566
Kroegel, C.; Chilvers, E.R.; Giembycz, M.A.; Challiss, R.A.; Barnes, P.J. 1991: Platelet-activating factor stimulates a rapid accumulation of inositol (1,4,5)trisphosphate in guinea pig eosinophils: relationship to calcium mobilization and degranulation. Journal of Allergy and Clinical Immunology 88(1): 114-124
Kawaguchi, H.; Sawa, H.; Iizuka, K.; Yasuda, H. 1990: Platelet-activating factor stimulates angiotensin converting enzyme activity. Journal of Hypertension 8(2): 173-177
Levine, L. 1988: Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism. Molecular Pharmacology 34(6): 793-799
Wu, T.; Lundgren, J.D.; Rieves, R.D.; Doerfler, M.E.; Logun, C.; Shelhamer, J.H. 1991: Platelet-activating factor stimulates eicosanoid production in cultured feline tracheal explants. Experimental Lung Research 17(6): 1079-1094
Barthelson, R.A.; Valone, F.H. 1991: Platelet-activating factor stimulates expression of IL-1 beta mRNA in THP-1 cells. Lipids 26(3): 257-260
Okayasu, T.; Hasegawa, K.; Ishibashi, T. 1987: Platelet-activating factor stimulates metabolism of phosphoinositides via phospholipase A2 in primary cultured rat hepatocytes. Journal of Lipid Research 28(7): 760-767
Hellstrom, W.J.; Wang, R.; Sikka, S.C. 1991: Platelet-activating factor stimulates motion parameters of cryopreserved human sperm. Fertility and Sterility 56(4): 768-770
Varol, F.G.; Hadjiconstantinou, M.; Travers, J.B.; Neff, N.H. 1989: Platelet-activating factor stimulates phosphatidylinositol hydrolysis in the rat myometrium. European Journal of Pharmacology 159(1): 97-98
Ahmed, A.; Smith, S.K. 1992: Platelet-activating factor stimulates phospholipase C activity in human endometrium. Journal of Cellular Physiology 152(1): 207-214
Shibata, Y.; Ogura, N.; Moriya, Y.; Abiko, Y.; Izumi, H.; Takiguchi, H. 1991: Platelet-activating factor stimulates production of prostaglandin E2 in murine osteoblast-like cell line MC3T3-E1. Life Sciences 49(15): 1103-1109
Camoratto, A.M.; Grandison, L. 1989: Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro. Endocrinology 124(3): 1502-1506
Kawaguchi, H.; Yasuda, H. 1986: Platelet-activating factor stimulates prostaglandin synthesis in cultured cells. Hypertension 8(3): 192-197
Pustynnikov, M.G.; Porodenko, N.V.; Makarova, O.V.; Kozyukov, A.V.; Moskaleva EYu; Sokolovsky, A.A.; Severin, E.S. 1991: Platelet-activating factor stimulates receptor-mediated formation of reactive oxygen intermediates in human monocytes. Lipids 26(12): 1214-1217
Goswami, S.K.; Ohashi, M.; Stathas, P.; Marom, Z.M. 1989: Platelet-activating factor stimulates secretion of respiratory glycoconjugate from human airways in culture. Journal of Allergy and Clinical Immunology 84(5 Part 1): 726-734
Rayner, T.E.; Menadue, M.F.; Oliver, J.R. 1991: Platelet-activating factor stimulates the release of atrial natriuretic factor from the rat heart. Journal of Endocrinology 130(2): 281-288
Sugatani, J.; Miwa, M.; Hanahan, D.J. 1987: Platelet-activating factor stimulation of rabbit platelets is blocked by serine protease inhibitor (chymotryptic protease inhibitor). Journal of Biological Chemistry 262(12): 5740-5747
Dhar, A.; Paul, A.K.; Shukla, S.D. 1990: Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine. Molecular Pharmacology 37(4): 519-525
Balsinde, J.; Mollinedo, F. 1991: Platelet-activating factor synergizes with phorbol myristate acetate in activating phospholipase D in the human promonocytic cell line U937. Evidence for different mechanisms of activation. Journal of Biological Chemistry 266(28): 18726-18730
Hogaboam, C.M.; Donigi-Gale, D.; Shoupe, T.S.; Bissonnette, E.Y.; Befus, A.D.; Wallace, J.L. 1992: Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. British Journal of Pharmacology 105(1): 87-92
Heuer, H.O.; Darius, H.; Lohmann, H.F.; Meyer, J.; Schierenberg, M.; Treese, N. 1991: Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. Lipids 26(12): 1381-1385
Taylor, M.B.; Zweiman, B.; Moskovitz, A.R.; von Allmen, C.; Atkins, P.C. 1990: Platelet-activating factor- and leukotriene B4-induced release of lactoferrin from blood neutrophils of atopic and nonatopic individuals. Journal of Allergy and Clinical Immunology 86(5): 740-748
Rachmilewitz, D.; Karmeli, F.; Eliakim, R. 1990: Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis. Scandinavian Journal of Gastroenterology. Suppl 172: 19-21
Bussolino, F.; Biffignandi, P.; Arese, P. 1986: Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. Acta Haematologica 75(3): 129-140
Frerichs, K.U.; Feuerstein, G.Z. 1990: Platelet-activating factor--key mediator in neuroinjury?. Cerebrovascular and Brain Metabolism Reviews 2(2): 148-160
Brunelleschi, S.; Haye-Legrand, I.; Labat, C.; Norel, X.; Benveniste, J.; Brink, C. 1987: Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium. Journal of Pharmacology and Experimental Therapeutics 243(1): 356-363
Matsumoto, M.; Miwa, M. 1985: Platelet-activating factor-binding protein in human serum. Advances in Prostaglandin Thromboxane and Leukotriene Research 15: 705-706
Ebisawa, M.; Saito, H.; Iikura, Y. 1990: Platelet-activating factor-induced activation and cytoskeletal change in cultured eosinophils. International Archives of Allergy and Applied Immunology 93(2-3): 93-98
Rabovsky, J.; Goddard, M.; Pailes, W.H.; Judy, D.J.; Castranova, V. 1990: Platelet-activating factor-induced aggregation of rat alveolar macrophages. Research Communications in Chemical Pathology and Pharmacology 69(2): 163-172
Selak, M.A.; Smith, J.B. 1989: Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists. Journal of Lipid Mediators 1(2): 125-137
Del Monte, M.; Subissi, A. 1988: Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites. Naunyn-Schmiedeberg's Archives of Pharmacology 338(4): 417-421
Felix, S.B.; Steger, A.; Baumann, G.; Busch, R.; Ochsenfeld, G.; Berdel, W.E. 1990: Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086. Journal of Lipid Mediators 2(1): 9-20
Inoue, T.; Kannan, M.S. 1989: Platelet-activating factor-induced functional changes in the guinea pig trachea in vitro. Respiration Physiology 77(2): 157-171
Schwertschlag, U.S.; Whorton, A.R. 1988: Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells. Journal of Biological Chemistry 263(27): 13791-13796
Huang, S.J.; Monk, P.N.; Downes, C.P.; Whetton, A.D. 1988: Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. Biochemical Journal 249(3): 839-845
Rihoux, J.P.; Fadel, R.; Juhlin, L. 1991: Platelet-activating factor-induced immediate and late cutaneous reactions. International Archives of Allergy and Applied Immunology 94(1-4): 299-300
Lang, C.H.; Dobrescu, C.; Hargrove, D.M.; Bagby, G.J.; Spitzer, J.J. 1988: Platelet-activating factor-induced increases in glucose kinetics. American Journal of Physiology 254(2 Part 1): E193-E200
Kubes, P.; Suzuki, M.; Granger, D.N. 1990: Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. American Journal of Physiology 258(1 Part 1): G158-G163
Kubes, P.; Arfors, K.E.; Granger, D.N. 1991: Platelet-activating factor-induced mucosal dysfunction: role of oxidants and granulocytes. American Journal of Physiology 260(6 Part 1): G965-G971
Barzaghi, G.; Sarau, H.M.; Mong, S. 1989: Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture. Journal of Pharmacology and Experimental Therapeutics 248(2): 559-566
Stewart, A.G.; Piper, P.J. 1986: Platelet-activating factor-induced vasoconstriction in rat isolated, perfused hearts: contribution of cyclo-oxygenase and lipoxygenase arachidonic acid metabolites. Pharmacological Research Communications 18 Suppl: 163-172
Gandhi, C.R.; DeBuysere, M.S.; Olson, M.S. 1992: Platelet-activating factor-mediated synthesis of prostaglandins in rat Kupffer cells. Biochimica et Biophysica Acta 1136(1): 68-74
Mazer, B.D.; Sawami, H.; Tordai, A.; Gelfand, E.W. 1992: Platelet-activating factor-mediated transmembrane signaling in human B lymphocytes is regulated through a pertussis- and cholera toxin-sensitive pathway. Journal of Clinical Investigation 90(3): 759-765
Buxton, D.B.; Fisher, R.A.; Hanahan, D.J.; Olson, M.S. 1986: Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. Journal of Biological Chemistry 261(2): 644-649
Wardlaw, A.J.; Moqbel, R.; Cromwell, O.; Kay, A.B. 1986: Platelet-activating factor. a potent chemotactic and chemokinetic factor for human eosinophils. Journal of Clinical Investigation 78(6): 1701-1706
Feuerstein, G.; Yue, T.L.; Lysko, P.G. 1990: Platelet-activating factor. a putative mediator in central nervous system injury?. Stroke 21(11 Suppl): Iii90-Iii94
Demopoulos, C.A.; Pinckard, R.N.; Hanahan, D.J. 1979: Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). Journal of Biological Chemistry 254(19): 9355-9358
Porcellini, G. 1986: Platelet-activating factor: a new biochemical and pharmacologic frontier. La Clinica Terapeutica 117(2): 127-132
Hanahan, D.J. 1992: Platelet-activating factor: a novel lipid agonist. Current Topics in Cellular Regulation 33: 65-78
Braquet, P.; Paubert-Braquet, M.; Bessin, P.; Vargaftig, B.B. 1987: Platelet-activating factor: a potential mediator of shock. Advances in Prostaglandin Thromboxane and Leukotriene Research 17b: 822-827
Hanahan, D.J.; Buxton, D.; Halvorsen, O.; Olson, M.S. 1985: Platelet-activating factor: a unique lipid chemical mediator. Advances in Prostaglandin Thromboxane and Leukotriene Research 15: 707-709
Snyder, F.; Lee, T.C.; Blank, M.; Malone, B.; Woodard, D.; Robinson, M. 1985: Platelet-activating factor: alternate pathways of biosynthesis, mechanism of inactivation, and reacylation of lyso-PAF with arachidonate. Advances in Prostaglandin Thromboxane and Leukotriene Research 15: 693-696
Hsueh, W.; González-Crussi, F.; Arroyave, J.L. 1987: Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 1(5): 403-405
Mózes, T.; Braquet, P.; Filep, J. 1989: Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. American Journal of Physiology 257(4 Part 2): R872-R877
McCormack, D.G.; Barnes, P.J.; Evans, T.W. 1990: Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction. Critical Care Medicine 18(12): 1398-1402
Porras-Reyes, B.H.; Mustoe, T.A. 1992: Platelet-activating factor: improvement in wound healing by a chemotactic factor. Surgery 111(4): 416-423
Shigenobu, K.; Mori, T.; Kamata, K.; Kasuya, Y. 1989: Platelet-activating factor: lack of direct action on guinea pig myocardium and possible transmitter release from cardiac sympathetic nerve endings at high concentrations. Canadian Journal of Physiology and Pharmacology 67(6): 669-674
Sturk, A.; Schaap, M.C.; ten Cate, J.W.; Heymans, H.S.; Schutgens, R.B.; Przyrembel, H.; Borst, P. 1987: Platelet-activating factor: mediator of the third pathway of platelet aggregation? a study in three patients with deficient platelet-activating factor synthesis. Journal of Clinical Investigation 79(2): 344-350
Bette-Bobillo, P.; Bienvenue, A. 1988: Platelet-activating-factor-induced serum-albumin release from rabbit platelets in the absence of calcium. European Journal of Biochemistry 177(3): 643-647
Porzsolt, F.; Thomä, J.; Unsöld, M.; Wolf, W.; Obert, H.J.; Kubanek, B.; Heimpel, H. 1985: Platelet-adjusted IFN dosage in the treatment of advanced hairy cell leukemia. Blut 51(2): 73-82
Siddiqui, F.A.; Lian, E.C. 1988: Platelet-agglutinating protein P37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G. Blood 71(2): 299-304
Siddiqui, F.A.; Lian, E.C. 1992: Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36). Biochemistry International 27(3): 485-496
Tohgo, A.; Tanaka, N.G.; Ogawa, H. 1985: Platelet-aggregating activities of metastasizing tumor cells. III. Platelet aggregation as resulting from thrombin generation by tumor cells. Invasion and Metastasis 5(2): 96-105
Tohgo, A.; Tanaka, N.G.; Ogawa, H. 1986: Platelet-aggregating activities of metastasizing tumor cells. IV. Effects of cell surface modification on thrombin generation, platelet aggregation and subsequent lung colonization. Invasion and Metastasis 6(1): 58-68
Tanaka, N.G.; Tohgo, A.; Ogawa, H. 1986: Platelet-aggregating activities of metastasizing tumor cells. V. in situ roles of platelets in hematogenous metastases. Invasion and Metastasis 6(4): 209-224
Nwagwu, M.; Inyang, A.L.; Molokwu, R.I.; Essien, E.M. 1989: Platelet-aggregating activity of released factor(s) from Trypanosoma brucei brucei. African Journal of Medicine and Medical Sciences 18(4): 283-287
Barnes, M.J.; Gordon, J.L.; MacIntyre, D.E. 1976: Platelet-aggregating activity of type i and type IIi collagens from human aorta and chicken skin. Biochemical Journal 160(3): 647-651
Atkins, J.N. 1985: Platelet-aggregating factor in thrombotic thrombocytopenic purpura. Annals of Internal Medicine 102(4): 560-561
Ansell, J.E.; Slepchuk, N.I.; Pechet, L. 1979: Platelet-aggregating factor in thrombotic thrombopenic purpura plasma. Blood 54(4): 959-960
Ogilvie, M.L.; Byl, J.W.; Gartner, T.K. 1989: Platelet-aggregation is stimulated by lactose-inhibitable snake venom lectins. Thrombosis and Haemostasis 62(2): 704-707
Cerletti, C.; Carriero, M.R.; de Gaetano, G. 1986: Platelet-aggregation response to single or paired aggregating stimuli after low-dose aspirin. New England Journal of Medicine 314(5): 316-318
Frampton, G.; Perl, S.; Bennett, A.; Cameron, J.S. 1986: Platelet-associated DNA and anti-DNA antibody in systemic lupus erythematosus with nephritis. Clinical and Experimental Immunology 63(3): 621-628
Jin, Z.J. 1987: Platelet-associated IgG and circulating immune complexes in various disorders. Japanese Journal of Clinical Hematology 28(3): 366-370
Lazarchick, J.; Hall, S.A. 1986: Platelet-associated IgG assay using flow cytometric analysis. Journal of Immunological Methods 87(2): 257-265
Ljung, R.; Nilsson, I.M.; Frohm, B.; Holmberg, L. 1986: Platelet-associated IgG in childhood idiopathic thrombocytopenic purpura: measurements on intact and solubilized platelets and after gammaglobulin treatment. Scandinavian Journal of Haematology 36(4): 402-407
Bennett, A.; Frampton, G.; Cameron, J.S. 1986: Platelet-associated IgG in idiopathic glomerulonephritis and the nephritis of systemic lupus erythematosus. British Journal of Haematology 62(4): 695-703
Luiken, G.A.; McMillan, R.; Lightsey, A.L.; Gordon, P.; Zevely, S.; Schulman, I.; Gribble, T.J.; Longmire, R.L. 1977: Platelet-associated IgG in immune thrombocytopenic purpura. Blood 50(2): 317-325
Ellaurie, M.; Burns, E.R.; Rubinstein, A. 1991: Platelet-associated IgG in pediatric HIV infection. Pediatric Hematology and Oncology 8(2): 179-185
Kekomäki, R.; Kekomäki, M.; Elfving, J. 1979: Platelet-associated IgG in septicemia. New England Journal of Medicine 301(5): 271
Vos, J.J.; Huisman, J.G.; van der Lelie, J.; von dem Borne, A.E. 1987: Platelet-associated IgG in thrombocytopenia: a comparison of two techniques. Vox Sanguinis 53(3): 162-168
Steiner, M. 1985: Platelet-associated IgG is a specific protein. Biochemical and Biophysical Research Communications 129(1): 206-212
Forster, J.; Katzikadamos, Z.; Zinn, P. 1989: Platelet-associated IgG, IgM, and C3 in paediatric infectious disease. Helvetica Paediatrica Acta 43(5-6): 415-422
McMillan, R.; Tani, P.; Millard, F.; Berchtold, P.; Renshaw, L.; Woods, V.L. 1987: Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 70(4): 1040-1045
Giddings, J.C.; Shearn, S.A.; Bloom, A.L. 1978: Platelet-associated coagulation factors: immunological detection and the effect of calcium. British Journal of Haematology 39(4): 569-577
Kurata, Y.; Curd, J.G.; Tamerius, J.D.; McMillan, R. 1985: Platelet-associated complement in chronic ITP. British Journal of Haematology 60(4): 723-733
Lauper, M.; Castelli, D.; Buchs, J.; Pichler, W.; Nydegger, U. 1988: Platelet-associated immunoglobulin G (PAIgG) and circulating immune complexes in asymptomatic and symptomatic HIV-seropositive patients. Schweizerische Medizinische Wochenschrift 118(49): 1847-1850
Lightsey, A.L.; Koenig, H.M.; McMillan, R.; Stone, J.R. 1979: Platelet-associated immunoglobulin G in childhood idiopathic thrombocytopenic purpura. Journal of Pediatrics 94(2): 201-204
Corash, L.; Shafer, B.; Blaese, R.M. 1985: Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood 65(6): 1439-1443
Panzer, S.; Szamait, S.; Bödeker, R.H.; Haas, O.A.; Haubenstock, A.; Mueller-Eckhardt, C. 1986: Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3 in immune and nonimmune thrombocytopenic disorders. American Journal of Hematology 23(2): 89-99
Panzer, S.; Niessner, H.; Lechner, K.; Dudczak, R.; Jäger, U.; Mayr, W.R. 1986: Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3c in chronic idiopathic autoimmune thrombocytopenia: relation to the sequestration pattern of 111indium labelled platelets. Scandinavian Journal of Haematology 37(2): 97-102
Han, P.; Kiruba, R.; Ho, Y.C. 1990: Platelet-associated immunoproteins (PAIg): specificity of measurement. Clinical and Laboratory Haematology 12(1): 49-56
Miller, W.R.; Dawes, J. 1985: Platelet-associated proteins in human breast cyst fluids. Clinica Chimica Acta; International Journal of Clinical Chemistry 152(1-2): 37-42
Rote, N.S.; Lau, R.J.; Harrison, M.R.; Branch, D.W.; Scott, J.R. 1987: Platelet-binding immunoglobulins in pregnancy-induced hypertension. I. Platelet-associated IgM on fetal platelets: evidence of a fetal autoimmune reaction?. Journal of Reproductive Immunology 10(4): 261-272
Rote, N.S.; Harrison, M.R.; Scott, J.R. 1987: Platelet-binding immunoglobulins in pregnancy-induced hypertension. II. Origin of circulating IgG and IgM antiplatelet antibodies in the umbilical cord serum. Journal of Reproductive Immunology 10(4): 273-284
Green, D.; Muller, H.P. 1978: Platelet-binding of the von Willebrand factor. Thrombosis and Haemostasis 39(3): 689-694
Somerville, B.W. 1976: Platelet-bound and free serotonin levels in jugular and forearm venous blood during migraine. Neurology 26(1): 41-45
Hauch, T.W.; Rosse, W.F. 1977: Platelet-bound complement (C3) in immune thrombocytopenia. Blood 50(6): 1129-1136
Green, D.; Potter, E.V. 1976: Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease. Journal of Laboratory and Clinical Medicine 87(6): 976-986
Laduca, F.M.; Bell, W.R.; Bettigole, R.E. 1987: Platelet-collagen adhesion enhances platelet aggregation induced by binding of VWF to platelets. American Journal of Physiology 253(5 Part 2): H1208-H1214
Chiang, T.M.; Jin, A.; Kang, A.H. 1987: Platelet-collagen interaction. Inhibition by a monoclonal antibody raised against collagen receptor. Journal of Immunology 139(3): 887-892
Balleisen, L.; Marx, R.; Kühn, K. 1976: Platelet-collagen interaction. the influence of native and modified collagen (Type I) on the aggregation of human platelets. Haemostasis 5(3): 155-164
Fauvel, F.; Legrand, Y.J.; Bentz, H.; Fietzek, P.P.; Kuhn, K.; Caen, J.P. 1978: Platelet-collagen interaction: adhesion of human blood platelets to purified (CB4) peptide from type IIi collagen. Thrombosis Research 12(5): 841-850
LaDuca, F.M.; Bettigole, R.E.; Bell, W.R.; Robson, E.B. 1986: Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding. Blood 68(4): 927-937
Legrand, Y.; Fauvel, F.; Caen, J.P. 1977: Platelet-collagen interactions. Comprehensive Therapy 3(6): 59-66
Johnson, R.J.; Pritzl, P.; Iida, H.; Alpers, C.E. 1991: Platelet-complement interactions in mesangial proliferative nephritis in the rat. American Journal of Pathology 138(2): 313-321
Collier, A.; Watson, H.H.; Matthews, D.M.; Strain, L.; Ludlam, C.A.; Clarke, B.F. 1986: Platelet-density analysis and intraplatelet granule content in young insulin-dependent diabetics. Diabetes 35(10): 1081-1084
Laghi Pasini, F.; Ceccatelli, L.; Pasqui, A.L.; Orrico, A.; Capecchi, P.L.; Di Perri, T. 1985: Platelet-dependent granulocyte activation in vitro: effect of ticlopidine. International Journal of Tissue Reactions 7(5): 367-372
Caswell, A.M.; Russell, R.G. 1989: Platelet-derived ATP may contribute to the measured concentration of inorganic pyrophosphate in serum. Clinical Chemistry 35(2): 326
Tavassoli, M.; Yelenosky, R. 1977: Platelet-derived acid phosphatase isoenzyme in the serum in thrombocythemia. American Journal of Clinical Pathology 67(2): 177-179
Rutherford, R.B.; Niekrash, C.E.; Kennedy, J.E.; Charette, M.F. 1992: Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. Journal of Periodontal Research 27(4 Part 1): 285-290
Cooper, T.W.; Eisen, A.Z.; Stricklin, G.P.; Welgus, H.G. 1985: Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proceedings of the National Academy of Sciences of the United States of America 82(9): 2779-2783
Heldin, C.H.; Usuki, K.; Miyazono, K. 1991: Platelet-derived endothelial cell growth factor. Journal of Cellular Biochemistry 47(3): 208-210
Usuki, K.; Saras, J.; Waltenberger, J.; Miyazono, K.; Pierce, G.; Thomason, A.; Heldin, C.H. 1992: Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochemical and Biophysical Research Communications 184(3): 1311-1316
Miyazono, K.; Takaku, F. 1991: Platelet-derived endothelial cell growth factor: structure and function. Japanese Circulation Journal 55(10): 1022-1026
Hunziker, T.; Nydegger, U.E.; Lerch, P.G.; Vassalli, J.D. 1986: Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures. Clinical and Experimental Immunology 64(2): 442-449
Miyazono, K. 1992: Platelet-derived growth factor. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 81(1): 117-121
Pierce, G.F.; Tarpley, J.E.; Yanagihara, D.; Mustoe, T.A.; Fox, G.M.; Thomason, A. 1992: Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. American Journal of Pathology 140(6): 1375-1388
Shimokado, K.; Numano, F. 1987: Platelet-derived growth factor (PDGF). Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 71: 209-216
Rorsman, F.; Leveen, P.; Betsholtz, C. 1992: Platelet-derived growth factor (PDGF) A-chain mRNA heterogeneity generated by the use of alternative promoters and alternative polyadenylation sites. Growth Factors 7(3): 241-251
Kimura, I.; Naitoh, T.; Okabe, M.; Kimura, M. 1992: Platelet-derived growth factor (PDGF) accelerates induction of competence, and heparin does not inhibit PDGF-induced competence in primary cultured smooth muscle cells of rat aorta. Japanese Journal of Pharmacology 59(1): 51-56
Diliberto, P.A.; Gordon, G.W.; Yu, C.L.; Earp, H.S.; Herman, B. 1992: Platelet-derived growth factor (PDGF) alpha receptor activation modulates the calcium mobilizing activity of the PDGF beta receptor in Balb/c3T3 fibroblasts. Journal of Biological Chemistry 267(17): 11888-11897
Iida, H.; Seifert, R.; Alpers, C.E.; Gronwald, R.G.; Phillips, P.E.; Pritzl, P.; Gordon, K.; Gown, A.M.; Ross, R.; Bowen-Pope, D.F. 1991: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proceedings of the National Academy of Sciences of the United States of America 88(15): 6560-6564
Kumjian, D.A.; Wahl, M.I.; Rhee, S.G.; Daniel, T.O. 1989: Platelet-derived growth factor (PDGF) binding promotes physical association of PDGF receptor with phospholipase C. Proceedings of the National Academy of Sciences of the United States of America 86(21): 8232-8236
Ariad, S.; Seymour, L.; Bezwoda, W.R. 1991: Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: correlation with stage and rate of progression. Breast Cancer Research and Treatment 20(1): 11-17
Guillausseau, P.J.; Dupuy, E.; Bryckaert, M.C.; Timsit, J.; Chanson, P.; Tobelem, G.; Caen, J.P.; Lubetzki, J. 1989: Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus. European Journal of Clinical Investigation 19(2): 172-175
Fleming, T.P.; Matsui, T.; Aaronson, S.A. 1992: Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy. Experimental Gerontology 27(5-6): 523-532
Kelly, J.D.; Haldeman, B.A.; Grant, F.J.; Murray, M.J.; Seifert, R.A.; Bowen-Pope, D.F.; Cooper, J.A.; Kazlauskas, A. 1991: Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. Journal of Biological Chemistry 266(14): 8987-8992
Chegini, N.; Rossi, M.J.; Masterson, B.J. 1992: Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF beta-receptors in human endometrial tissue: localization and in vitro action. Endocrinology 130(4): 2373-2385
Morrison, D.K.; Kaplan, D.R.; Rhee, S.G.; Williams, L.T. 1990: Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex. Molecular and Cellular Biology 10(5): 2359-2366
Li, W.; Schlessinger, J. 1991: Platelet-derived growth factor (PDGF)-induced disulfide-linked dimerization of PDGF receptor in living cells. Molecular and Cellular Biology 11(7): 3756-3761
Mercola, M.; Melton, D.A.; Stiles, C.D. 1988: Platelet-derived growth factor a chain is maternally encoded in Xenopus embryos. Science 241(4870): 1223-1225
Bonthron, D.; Collins, T.; Grzeschik, K.H.; van Roy, N.; Speleman, F. 1992: Platelet-derived growth factor a chain: confirmation of localization of PDGFA to chromosome 7p22 and description of an unusual minisatellite. Genomics 13(2): 257-263
Bonthron, D.T.; Morton, C.C.; Orkin, S.H.; Collins, T. 1988: Platelet-derived growth factor a chain: gene structure, chromosomal location, and basis for alternative mRNA splicing. Proceedings of the National Academy of Sciences of the United States of America 85(5): 1492-1496
Scott-Burden, T.; Resink, T.J.; Hahn, A.A.; Buhler, F.R. 1991: Platelet-derived growth factor A-chain homodimer stimulated growth of cultured smooth muscle cells from spontaneously hypertensive rats. Clinical and Experimental Hypertension. Part A Theory and Practice 13(5): 763-772
Soma, Y.; Dvonch, V.; Grotendorst, G.R. 1992: Platelet-derived growth factor AA homodimer is the predominant isoform in human platelets and acute human wound fluid. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 6(11): 2996-3001
Tsukamoto, T.; Matsui, T.; Fukase, M.; Fujita, T. 1991: Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1). Biochemical and Biophysical Research Communications 175(3): 745-751
Sasahara, A.; Kott, J.N.; Sasahara, M.; Raines, E.W.; Ross, R.; Westrum, L.E. 1992: Platelet-derived growth factor B-chain-like immunoreactivity in the developing and adult rat brain. Brain Research. Developmental Brain Research 68(1): 41-53
Robson, M.C.; Phillips, L.G.; Thomason, A.; Robson, L.E.; Pierce, G.F. 1992: Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 339(8784): 23-25
Shimada, M.; Inaba, T.; Shimano, H.; Gotoda, T.; Watanabe, Y.; Yamamoto, K.; Motoyoshi, K.; Yazaki, Y.; Yamada, N. 1992: Platelet-derived growth factor BB-dimer suppresses the expression of macrophage colony-stimulating factor in human vascular smooth muscle cells. Journal of Biological Chemistry 267(22): 15455-15458
Welsh, C.J.; Schmeichel, K.; McBride, K. 1991: Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells. In Vitro Cellular and Developmental Biology; Journal of the Tissue Culture Association 27(5): 425-431
Slomiany, B.L.; Liu, J.; Slomiany, A. 1992: Platelet-derived growth factor activation of gastric mucosal calcium channels. Biochemical and Biophysical Research Communications 186(3): 1496-1502
Golden, M.A.; Au, Y.P.; Kirkman, T.R.; Wilcox, J.N.; Raines, E.W.; Ross, R.; Clowes, A.W. 1991: Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation. Journal of Clinical Investigation 87(2): 406-414
Johnsson, A.; Betsholtz, C.; von der Helm, K.; Heldin, C.H.; Westermark, B. 1985: Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product. Proceedings of the National Academy of Sciences of the United States of America 82(6): 1721-1725
Kumkumian, G.K.; Lafyatis, R.; Remmers, E.F.; Case, J.P.; Kim, S.J.; Wilder, R.L. 1989: Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription. Journal of Immunology 143(3): 833-837
Roe, M.W.; Hepler, J.R.; Harden, T.K.; Herman, B. 1989: Platelet-derived growth factor and angiotensin Ii cause increases in cytosolic free calcium by different mechanisms in vascular smooth muscle cells. Journal of Cellular Physiology 139(1): 100-108
Heldin, C.H.; Westermark, B. 1991: Platelet-derived growth factor and autocrine mechanisms of oncogenic processes. Critical Reviews in Oncogenesis 2(2): 109-124
Zullo, J.N.; Cochran, B.H.; Huang, A.S.; Stiles, C.D. 1985: Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 43(3 Part 2): 793-800
Nakashima, N.; Umeda, F.; Yamauchi, T.; Ishii, H.; Hisatomi, A.; Nawata, H.; Masuko, H.; Nakayama, K.; Tatematsu, A. 1992: Platelet-derived growth factor and growth-promoting activity in the serum samples and platelets of patients with non-insulin-dependent diabetes mellitus. Journal of Laboratory and Clinical Medicine 120(1): 78-85
Buch, S.; Jones, C.; Sweezey, N.; Tanswell, K.; Post, M. 1991: Platelet-derived growth factor and growth-related genes in rat lung. I. Developmental expression. American Journal of Respiratory Cell and Molecular Biology 5(4): 371-376
Majack, R.A.; Cook, S.C.; Bornstein, P. 1985: Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. Journal of Cell Biology 101(3): 1059-1070
Sprugel, K.H.; Greenhalgh, D.G.; Murray, M.J.; Ross, R. 1991: Platelet-derived growth factor and impaired wound healing. Progress in Clinical and Biological Research 365: 327-340
Pantazis, P.; Goustin, A.S.; Nixon, J. 1990: Platelet-derived growth factor and its receptor in blood cell differentiation and neoplasia. European Journal of Haematology 45(3): 127-138
Hermanson, M.; Funa, K.; Hartman, M.; Claesson-Welsh, L.; Heldin, C.H.; Westermark, B.; Nistér, M. 1992: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Research 52(11): 3213-3219
Tennant, M.; McGeachie, J.K. 1991: Platelet-derived growth factor and its role in atherogenesis: a brief review. Australian and New Zealand Journal of Surgery 61(7): 482-488
Ross, R.; Bowen-Pope, D.F.; Raines, E.W. 1990: Platelet-derived growth factor and its role in health and disease. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 327(1239): 155-169
Mitsumata, M.; Yoshida, Y. 1988: Platelet-derived growth factor and mechanism of cell proliferation of arterial smooth muscle: hyperlipidemia and cell proliferation of arterial smooth muscle. Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 608-614
Shimokado, K.; Tsukada, T.; Numano, F. 1988: Platelet-derived growth factor and mechanism of cell proliferation of arterial smooth muscle: macrophage-derived growth factor and arteriosclerosis. Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 600-607
Kaji, K.; Shimada, Y. 1988: Platelet-derived growth factor and mechanism of cell proliferation of arterial smooth muscle: progress in the study of the molecular biology of platelet-derived growth factor and atherosclerosis. Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 590-599
Sakamoto, H.; Ooyama, T. 1988: Platelet-derived growth factor and mechanism of cell proliferation of arterial smooth muscle: vascular elastic fibers and migration of vascular smooth muscle cells. Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 615-620
Sinzinger, H.; Zidek, T.; Foegh, M.L. 1987: Platelet-derived growth factor and prostacyclin in kidney transplant rejection. Transplantation Proceedings 19(4 Suppl 5): 102-107
Hardy, M.; Reddy, U.R.; Pleasure, D. 1992: Platelet-derived growth factor and regulation of Schwann cell proliferation in vivo. Journal of Neuroscience Research 31(2): 254-262
Scher, C.D.; Shepard, R.C.; Antoniades, H.N.; Stiles, C.D. 1979: Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle. Biochimica et Biophysica Acta 560(2): 217-241
Pierce, G.F.; Mustoe, T.A.; Lingelbach, J.; Masakowski, V.R.; Griffin, G.L.; Senior, R.M.; Deuel, T.F. 1989: Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. Journal of Cell Biology 109(1): 429-440
Reilly, C.F.; McFall, R.C. 1991: Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. Journal of Biological Chemistry 266(15): 9419-9427
Fine, R.M. 1989: Platelet-derived growth factor and vascular proliferative lesions of the skin. International Journal of Dermatology 28(3): 170-171
Westermark, B.; Heldin, C.H. 1986: Platelet-derived growth factor as a mediator of normal and neoplastic cell proliferation. Medical Oncology and Tumor PharmacoTherapy 3(3-4): 177-183
Olsen, R.A.; Seewald, M.J.; Melder, D.C.; Berggren, M.; Iaizzo, P.A.; Powis, G. 1991: Platelet-derived growth factor blocks the increase in intracellular free Ca2+ caused by calcium ionophores and a volatile anesthetic agent in Swiss 3T3 fibroblasts without altering toxicity. Toxicology Letters 55(1): 117-125
Bach, M.K.; Brashler, J.R.; Stout, B.K.; Johnson, H.G.; Sanders, M.E. 1991: Platelet-derived growth factor can activate purified primate, phorbol myristate acetate-primed eosinophils. International Archives of Allergy and Applied Immunology 94(1-4): 167-168
Gersuk, G.M.; Carmel, R.; Pattengale, P.K. 1989: Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders. Blood 74(7): 2330-2334
Bassett, J.E.; Bowen-Pope, D.F.; Takayasu, M.; Dacey, R.G. 1988: Platelet-derived growth factor does not constrict rat intracerebral arterioles in vitro. Microvascular Research 35(3): 368-373
Lin, A.H.; Groppi, V.E.; Gorman, R.R. 1988: Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene. Molecular and Cellular Biology 8(11): 5052-5055
Callahan, K.S.; Schorer, A.; Harlan, J.M. 1986: Platelet-derived growth factor does not stimulate prostacyclin synthesis by cultured endothelial cells. Blood 67(1): 131-134
Howes, R.; Bowness, J.M.; Grotendorst, G.R.; Martin, G.R.; Reddi, A.H. 1988: Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formation. Calcified Tissue International 42(1): 34-38
Centrella, M.; McCarthy, T.L.; Canalis, E. 1989: Platelet-derived growth factor enhances deoxyribonucleic acid and collagen synthesis in osteoblast-enriched cultures from fetal rat parietal bone. Endocrinology 125(1): 13-19
Delwiche, F.; Raines, E.; Powell, J.; Ross, R.; Adamson, J. 1985: Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells. Journal of Clinical Investigation 76(1): 137-142
Gesualdo, L.; Pinzani, M.; Floriano, J.J.; Hassan, M.O.; Nagy, N.U.; Schena, F.P.; Emancipator, S.N.; Abboud, H.E. 1991: Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Laboratory Investigation; a Journal of Technical Methods and Pathology 65(2): 160-167
Barrett, T.B.; Benditt, E.P. 1988: Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proceedings of the National Academy of Sciences of the United States of America 85(8): 2810-2814
Okamura, M.; Konishi, Y.; Nishimura, M.; Negoro, N.; Umetani, N.; Inoue, T.; Kanayama, Y.; Takeda, T. 1992: Platelet-derived growth factor gene expression in the kidney of malignant hypertension. Blood Pressure. Suppl 3: 17-21
Badalamente, M.A.; Hurst, L.C.; Grandia, S.K.; Sampson, S.P. 1992: Platelet-derived growth factor in Dupuytren's disease. Journal of Hand Surgery 17(2): 317-323
Westermark, B.; Heldin, C.H. 1991: Platelet-derived growth factor in autocrine transformation. Cancer Research 51(19): 5087-5092
Pringle, N.; Collarini, E.J.; Hart, I.K.; Raff, M.C.; Richardson, W.D. 1991: Platelet-derived growth factor in central nervous system gliogenesis. Annals of the New York Academy of Sciences 633: 160-168
Kondo, H.; Matsuda, R.; Yonezawa, Y. 1992: Platelet-derived growth factor in combination with collagen promotes the migration of human skin fibroblasts into a denuded area of a cell monolayer. Experimental Cell Research 202(1): 45-51
Silver, B.J. 1992: Platelet-derived growth factor in human malignancy. Biofactors 3(4): 217-227
Antoniades, H.N.; Bravo, M.A.; Avila, R.E.; Galanopoulos, T.; Neville-Golden, J.; Maxwell, M.; Selman, M. 1990: Platelet-derived growth factor in idiopathic pulmonary fibrosis. Journal of Clinical Investigation 86(4): 1055-1064
Kobayashi, S.; Nishimura, J.; Kanaide, H. 1992: Platelet-derived growth factor induces Ca2+ transients and proliferation of vascular smooth muscle cells: a role of tyrosine kinase. Japanese Journal of Pharmacology 58(Suppl 2): 412p
Inaba, T.; Gotoda, T.; Shimano, H.; Shimada, M.; Harada, K.; Kozaki, K.; Watanabe, Y.; Hoh, E.; Motoyoshi, K.; Yazaki, Y. 1992: Platelet-derived growth factor induces c-fms and scavenger receptor genes in vascular smooth muscle cells. Journal of Biological Chemistry 267(18): 13107-13112
Nishimura, J.; Kobayashi, S.; Shikasho, T.; Kanaide, H. 1992: Platelet-derived growth factor induces c-fos and c-myc mRNA in cultured rat aortic smooth muscle cells irrespective of intracellular Ca2+ levels. Japanese Journal of Pharmacology 58(Suppl 2): 413p
Chiou, W.J.; Bonin, P.D.; Harris, P.K.; Carter, D.B.; Singh, J.P. 1989: Platelet-derived growth factor induces interleukin-1 receptor gene expression in Balb/c 3T3 fibroblasts. Journal of Biological Chemistry 264(36): 21442-21445
Shawver, L.K.; Pierce, G.F.; Kawahara, R.S.; Deuel, T.F. 1989: Platelet-derived growth factor induces phosphorylation of a 64-kDa nuclear protein. Journal of Biological Chemistry 264(2): 1046-1050
Wahl, M.I.; Olashaw, N.E.; Nishibe, S.; Rhee, S.G.; Pledger, W.J.; Carpenter, G. 1989: Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells. Molecular and Cellular Biology 9(7): 2934-2943
Pfeilschifter, J. 1991: Platelet-derived growth factor inhibits cytokine induction of nitric oxide synthase in rat renal mesangial cells. European Journal of Pharmacology 208(4): 339-340
Besnard, F.; Perraud, F.; Sensenbrenner, M.; Labourdette, G. 1987: Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro. Neuroscience Letters 73(3): 287-292
Daynes, R.A.; Dowell, T.; Araneo, B.A. 1991: Platelet-derived growth factor is a potent biologic response modifier of T cells. Journal of Experimental Medicine 174(6): 1323-1333
Natarajan, R.; Nadler, J. 1992: Platelet-derived growth factor is a potent inhibitor of angiotensin II-induced aldosterone synthesis. Molecular and Cellular Endocrinology 83(1): 57-63
Risau, W.; Drexler, H.; Mironov, V.; Smits, A.; Siegbahn, A.; Funa, K.; Heldin, C.H. 1992: Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7(4): 261-266
Campochiaro, P.A.; Glaser, B.M. 1985: Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Archives of Ophthalmology 103(4): 576-579
Katoh, O.; Kimura, A.; Kuramoto, A. 1988: Platelet-derived growth factor is decreased in patients with myeloproliferative disorders. American Journal of Hematology 27(4): 276-280
Svalander, P.C.; Holmes, P.V.; Olovsson, M.; Wikland, M.; Gemzell-Danielsson, K.; Bygdeman, M. 1991: Platelet-derived growth factor is detected in human blastocyst culture medium but not in human follicular fluid--a preliminary report. Fertility and Sterility 56(2): 367-369
Wolswijk, G.; Riddle, P.N.; Noble, M. 1991: Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells. Glia 4(5): 495-503
Graves, D.T.; Grotendorst, G.R.; Antoniades, H.N.; Schwartz, C.J.; Valente, A.J. 1989: Platelet-derived growth factor is not chemotactic for human peripheral blood monocytes. Experimental Cell Research 180(2): 497-503
Giannella-Neto, D.; Kamyar, A.; Sharifi, B.; Pirola, C.J.; Kupfer, J.; Rosenfeld, R.G.; Forrester, J.S.; Fagin, J.A. 1992: Platelet-derived growth factor isoforms decrease insulin-like growth factor i gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circulation Research 71(3): 646-656
Wilcox, J.N.; Smith, K.M.; Williams, L.T.; Schwartz, S.M.; Gordon, D. 1988: Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. Journal of Clinical Investigation 82(3): 1134-1143
Nakajima, M.; Hewitson, T.D.; Mathews, D.C.; Kincaid-Smith, P. 1991: Platelet-derived growth factor mesangial deposits in mesangial IgA glomerulonephritis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 6(1): 11-16
Davis, R.J.; Czech, M.P. 1985: Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654. Proceedings of the National Academy of Sciences of the United States of America 82(12): 4080-4084
Olashaw, N.E.; O'Keefe, E.J.; Pledger, W.J. 1986: Platelet-derived growth factor modulates epidermal growth factor receptors by a mechanism distinct from that of phorbol esters. Proceedings of the National Academy of Sciences of the United States of America 83(11): 3834-3838
Palmer, H.; Maher, V.M.; McCormick, J.J. 1988: Platelet-derived growth factor or basic fibroblast growth factor induce anchorage-independent growth of human fibroblasts. Journal of Cellular Physiology 137(3): 588-592
Smith, R.J.; Justen, J.M.; Sam, L.M.; Rohloff, N.A.; Ruppel, P.L.; Brunden, M.N.; Chin, J.E. 1991: Platelet-derived growth factor potentiates cellular responses of articular chondrocytes to interleukin-1. Arthritis and Rheumatism 34(6): 697-706
Brody, A.R.; Bonner, J.C. 1991: Platelet-derived growth factor produced by pulmonary cells. Chest 99(3 Suppl): 50s-52s
Kaufman, B.R.; Fox, P.L.; Graham, L.M. 1992: Platelet-derived growth factor production by canine aortic grafts seeded with endothelial cells. Journal of Vascular Surgery 15(4): 699-706; Discussion: 706-707
Kourembanas, S.; Faller, D.V. 1989: Platelet-derived growth factor production by human umbilical vein endothelial cells is regulated by basic fibroblast growth factor. Journal of Biological Chemistry 264(8): 4456-4459
Tzeng, D.Y.; Deuel, T.F.; Huang, J.S.; Baehner, R.L. 1985: Platelet-derived growth factor promotes human peripheral monocyte activation. Blood 66(1): 179-183
Jawien, A.; Bowen-Pope, D.F.; Lindner, V.; Schwartz, S.M.; Clowes, A.W. 1992: Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. Journal of Clinical Investigation 89(2): 507-511
Palman, C.; Bowen-Pope, D.F.; Brooks, J.J. 1992: Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors. Laboratory Investigation; a Journal of Technical Methods and Pathology 66(1): 108-115
Stephenson, D.A.; Mercola, M.; Anderson, E.; Wang, C.Y.; Stiles, C.D.; Bowen-Pope, D.F.; Chapman, V.M. 1991: Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation. Proceedings of the National Academy of Sciences of the United States of America 88(1): 6-10
Higgy, N.; Davidoff, A.; Benediktsson, H.; Paul, L.C. 1991: Platelet-derived growth factor receptor expression in chronic rejection of cardiac and renal grafts in the rat. Transplantation Proceedings 23(1 Pt 1): 609-610
Keating, M.T.; Harryman, C.C.; Williams, L.T. 1989: Platelet-derived growth factor receptor inducibility is acquired immediately after translation and does not require glycosylation. Journal of Biological Chemistry 264(16): 9129-9132
Courtneidge, S.A.; Kypta, R.M.; Cooper, J.A.; Kazlauskas, A. 1991: Platelet-derived growth factor receptor sequences important for binding of src family tyrosine kinases. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 2(10): 483-486
Hart, C.E.; Bowen-Pope, D.F. 1990: Platelet-derived growth factor receptor: current views of the two-subunit model. Journal of Investigative Dermatology 94(6 Suppl): 53s-57s
Cunningham, L.D.; Brecher, P.; Cohen, R.A. 1992: Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta. Journal of Clinical Investigation 89(3): 878-882
Blank, R.S.; Owens, G.K. 1990: Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. Journal of Cellular Physiology 142(3): 635-642
Rollins, B.J.; Morrison, E.D.; Usher, P.; Flier, J.S. 1988: Platelet-derived growth factor regulates glucose transporter expression. Journal of Biological Chemistry 263(32): 16523-16526
Jackson, J.A.; Holt, J.T.; Pledger, W.J. 1992: Platelet-derived growth factor regulation of fos stability correlates with growth induction. Journal of Biological Chemistry 267(24): 17444-17448
Harrington, M.A.; Pledger, W.J. 1987: Platelet-derived growth factor stimulated mechanisms of glucosamine incorporation. American Journal of Physiology 253(4 Part 1): C567-C574
Satoh, T.; Endo, M.; Nakafuku, M.; Nakamura, S.; Kaziro, Y. 1990: Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proceedings of the National Academy of Sciences of the United States of America 87(15): 5993-5997
Wilson, E.; Laster, S.M.; Gooding, L.R.; Lambeth, J.D. 1987: Platelet-derived growth factor stimulates phagocytosis and blocks agonist-induced activation of the neutrophil oxidative burst: a possible cellular mechanism to protect against oxygen radical damage. Proceedings of the National Academy of Sciences of the United States of America 84(8): 2213-2217
Bu, X.; Hagedorn, C.H. 1991: Platelet-derived growth factor stimulates phosphorylation of the 25 kDa mRNA cap binding protein (eIF-4E) in human lung fibroblasts. Febs Letters 283(2): 219-222
Chu, S.H.; Hoban, C.J.; Owen, A.J.; Geyer, R.P. 1985: Platelet-derived growth factor stimulates rapid polyphosphoinositide breakdown in fetal human fibroblasts. Journal of Cellular Physiology 124(3): 391-396
Hata, Y.; Ogata, E.; Kojima, I. 1989: Platelet-derived growth factor stimulates synthesis of 1,2-diacylglycerol from monoacylglycerol in Balb/c 3T3 cells. Biochemical Journal 262(3): 947-952
Molloy, C.J.; Fleming, T.P.; Bottaro, D.P.; Cuadrado, A.; Aaronson, S.A. 1992: Platelet-derived growth factor stimulation of GTPase-activating protein tyrosine phosphorylation in control and c-H-ras-expressing NIH 3T3 cells correlates with p21ras activation. Molecular and Cellular Biology 12(9): 3903-3909
Harrington, M.A.; Wharton, W.; Pledger, W.J. 1987: Platelet-derived growth factor stimulation of [3H]-glucosamine incorporation in density-arrested BALB/c-3T3 cells. Journal of Cellular Physiology 130(1): 93-102
Silver, B.J.; Jaffer, F.E.; Abboud, H.E. 1989: Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proceedings of the National Academy of Sciences of the United States of America 86(3): 1056-1060
Bernabei, P.A.; Arcangeli, A.; Casini, M.; Grossi, A.; Padovani, R.; Rossi Ferrini, P. 1986: Platelet-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease. British Journal of Haematology 63(2): 353-357
Chen, Y.; Rabinovitch, P.S. 1989: Platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor i regulate specific cell-cycle parameters of human diploid fibroblasts in serum-free culture. Journal of Cellular Physiology 140(1): 59-67
Habenicht, A.J.; Salbach, P.; Janssen-Timmen, U.; Blattner, C.; Schettler, G. 1990: Platelet-derived growth factor--a growth factor with an expanding role in health and disease. Klinische Wochenschrift 68(2): 53-59
Ross, R.; Raines, E.W. 1988: Platelet-derived growth factor--its role in health and disease. Advances in Experimental Medicine and Biology 234: 9-21
Orr-Urtreger, A.; Lonai, P. 1992: Platelet-derived growth factor-A and its receptor are expressed in separate, but adjacent cell layers of the mouse embryo. Development 115(4): 1045-1058
Pierce, G.F.; Vande Berg, J.; Rudolph, R.; Tarpley, J.; Mustoe, T.A. 1991: Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. American Journal of Pathology 138(3): 629-646
Herman, B.; Pledger, W.J. 1985: Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells. Journal of Cell Biology 100(4): 1031-1040
Herman, B.; Roe, M.W.; Harris, C.; Wray, B.; Clemmons, D. 1987: Platelet-derived growth factor-induced alterations in vinculin distribution in porcine vascular smooth muscle cells. Cell Motility and the Cytoskeleton 8(2): 91-105
Frick, K.K.; Womer, R.B.; Scher, C.D. 1988: Platelet-derived growth factor-induced c-myc RNA expression. Analysis of an inducible pathway independent of protein kinase C. Journal of Biological Chemistry 263(6): 2948-2952
Finkenzeller, G.; Marmé, D.; Weich, H.A.; Hug, H. 1992: Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Research 52(17): 4821-4823
Kawahara, R.S.; Deuel, T.F. 1989: Platelet-derived growth factor-inducible gene JE is a member of a family of small inducible genes related to platelet factor 4. Journal of Biological Chemistry 264(2): 679-682
Hall, D.J.; Stiles, C.D. 1987: Platelet-derived growth factor-inducible genes respond differentially to at least two distinct intracellular second messengers. Journal of Biological Chemistry 262(31): 15302-15308
Frick, K.K.; Scher, C.D. 1990: Platelet-derived growth factor-stimulated c-myc RNA accumulation in MG-63 human osteosarcoma cells is independent of both protein kinase a and protein kinase C. Molecular and Cellular Biology 10(1): 184-192
Weich, H.A.; Herbst, D.; Schairer, H.U.; Hoppe, J. 1987: Platelet-derived growth factor. Phorbol ester induces the expression of the B-chain but not of the A-chain in HEL cells. Febs Letters 213(1): 89-94
Claesson-Welsh, L.; Heldin, C.H. 1989: Platelet-derived growth factor. Three isoforms that bind to two distinct cell surface receptors. Acta Oncologica 28(3): 331-334
Deuel, T.F.; Pierce, G.F.; Yeh, H.J.; Shawver, L.K.; Milner, P.G.; Kimura, A. 1987: Platelet-derived growth factor/sis in normal and neoplastic cell growth. Journal of Cellular Physiology. Suppl Suppl 5: 95-99
Guha, A. 1991: Platelet-derived growth factor: a general review with emphasis on astrocytomas. Pediatric Neurosurgery 17(1): 14-20
Deuel, T.F.; Silverman, N.J.; Kawahara, R.S. 1988: Platelet-derived growth factor: a multifunctional regulator of normal and abnormal cell growth. Biofactors 1(3): 213-217
Ross, R.; Bowen-Pope, D.F.; Raines, E.W. 1985: Platelet-derived growth factor: its potential roles in wound healing, atherosclerosis, neoplasia, and growth and development. Ciba Foundation Symposium 116: 98-112
Heldin, C.H.; Westermark, B. 1990: Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regulation 1(8): 555-566
Heldin, C.H.; Betsholtz, C.; Johnsson, A.; Nistér, M.; Ek, B.; Rönnstrand, L.; Wasteson, A.; Westermark, B. 1985: Platelet-derived growth factor: mechanism of action and relation to oncogenes. Journal of Cell Science. Suppl 3: 65-76
Antoniades, H.N.; Pantazis, P. 1989: Platelet-derived growth factor: purification and characterization. Methods in Enzymology 169: 210-224
Heldin, C.H.; Westermark, B.; Wasteson, A. 1979: Platelet-derived growth factor: purification and partial characterization. Proceedings of the National Academy of Sciences of the United States of America 76(8): 3722-3726
Deuel, T.F.; Kimura, A.; Maehama, S.; Tong, B.D. 1985: Platelet-derived growth factor: roles in normal and v-sis transformed cells. Cancer Surveys 4(4): 633-653
Westermark, B.; Heldin, C.H. 1989: Platelet-derived growth factor: structural and functional aspects. Journal of Internal Medicine 225(1): 55-58
Deuel, T.F.; Tong, B.D.; Huang, J.S. 1985: Platelet-derived growth factor: structure, function, and roles in normal and transformed cells. Current Topics in Cellular Regulation 26: 51-64
Heldin, C.H.; Westermark, B. 1989: Platelet-derived growth factor: three isoforms and two receptor types. Trends in Genetics: Tig 5(4): 108-111
Miyazono, K.; Takaku, F. 1989: Platelet-derived growth factors. Blood Reviews 3(4): 269-276
Davis, J.B.; Stroobant, P. 1990: Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells. Journal of Cell Biology 110(4): 1353-1360
Han, R.N.; Mawdsley, C.; Souza, P.; Tanswell, A.K.; Post, M. 1992: Platelet-derived growth factors and growth-related genes in rat lung. III. Immunolocalization during fetal development. Pediatric Research 31(4 Part 1): 323-329
Remmers, E.F.; Sano, H.; Wilder, R.L. 1991: Platelet-derived growth factors and heparin-binding (fibroblast) growth factors in the synovial tissue pathology of rheumatoid arthritis. Seminars in Arthritis and Rheumatism 21(3): 191-199
Heldin, C.H.; Westermark, B. 1989: Platelet-derived growth factors: a family of isoforms that bind to two distinct receptors. British Medical Bulletin 45(2): 453-464
Nakamura, T. 1987: Platelet-derived growth regulators and mechanism of liver regeneration. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 32(9): 1113-1125
Lane, D.A. 1985: Platelet-derived heparin neutralizing proteins. Advances in Experimental Medicine and Biology 192: 427-438
Hawrylowicz, C.M.; Howells, G.L.; Feldmann, M. 1991: Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. Journal of Experimental Medicine 174(4): 785-790
Fujisawa, K.; Akatsuka, J. 1992: Platelet-derived microparticles. Nihon Rinsho. Japanese Journal of Clinical Medicine 50(2): 342-348
Gilbert, G.E.; Sims, P.J.; Wiedmer, T.; Furie, B.; Furie, B.C.; Shattil, S.J. 1991: Platelet-derived microparticles express high affinity receptors for factor VIII. Journal of Biological Chemistry 266(26): 17261-17268
Romano, M.; Viero, P.; Cortellazzo, S.; Barbui, T.; Donati, M.B.; Poggi, A. 1990: Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders. Haemostasis 20(3): 162-168
Iwabuchi, K.; Yamashita, T. 1990: Platelet-derived neutrophil adherence-inhibiting factor in humans. Blood 76(11): 2368-2373
Vanhoutte, P.M. 1991: Platelet-derived serotonin, the endothelium, and cardiovascular disease. Journal of Cardiovascular Pharmacology 17(Suppl 5): S6-12
Holmsen, H.; Male, R.; Rongved, S.; Langeland, N.; Lillehaug, J. 1989: Platelet-derived-growth-factor-stimulated heterogeneous polyphosphoinositide metabolism and phosphate uptake in C3H fibroblasts. Biochemical Journal 260(2): 589-592
Lazarchick, J.; Graddick, S.L.; Hall, S.A.; Genco, P.V. 1987: Platelet-directed antibody in the serum of patients with primary thrombotic thrombocytopenic purpura. Annals of Clinical and Laboratory Science 17(5): 339-344
Gingrich, R.D.; Hoak, J.C. 1979: Platelet-endothelial cell interactions. Seminars in Hematology 16(3): 208-220
Nalbandian, R.M.; Henry, R.L. 1978: Platelet-endothelial cell interactions. Metabolic maps of structures and actions of prostaglandins, prostacyclin, thromboxane and cyclic AMP. Seminars in Thrombosis and Hemostasis 5(2): 87-111
Rabinovitch, M.; Turner-Gomes, S.O. 1989: Platelet-endothelial factors. Advances in Pediatrics 36: 91-115
Semeraro, N.; Fumarola, D.; Telesforo, P.; Vermylen, J. 1976: Platelet-endotoxin interaction: a review. Bollettino Dell'istituto Sieroterapico Milanese 55(6): 577-586
Takagi, Y.; Dyer, C.A.; Curtiss, L.K. 1988: Platelet-enhanced apolipoprotein e production by human macrophages: a possible role in atherosclerosis. Journal of Lipid Research 29(7): 859-867
Jen, C.J.; Hu, S.J.; Wu, H.J.; Lin, T.S.; Mao, C.W. 1990: Platelet-fibrin interaction in the suspension and under flow conditions. Advances in Experimental Medicine and Biology 281: 277-285
Vasdev, S.; Sampson, C.A.; Prabhakaran, V.M. 1991: Platelet-free calcium and vascular calcium uptake in ethanol-induced hypertensive rats. Hypertension 18(1): 116-122
Marx, R. 1978: Platelet-function -- assays and events: introduction. Supplementum .. Ad Thrombosis and Haemostasis 63: 65-80
Trachte, G.J.; Stein, E. 1988: Platelet-generated thromboxane A2 enhances norepinephrine release from adrenergic nerves. Journal of Pharmacology and Experimental Therapeutics 247(3): 1139-1145
Lindgren, J.A.; Edenius, C. 1990: Platelet-granulocyte interactions and the production of leukotrienes and lipoxins. Advances in Prostaglandin Thromboxane and Leukotriene Research 20: 63-70
Phillips, J.H.; Chang, C.W.; Lanier, L.L. 1991: Platelet-induced expression of Fc gamma RIIi (CD16) on human monocytes. European Journal of Immunology 21(4): 895-899
Maeda, T.; Nash, G.B.; Christopher, B.; Pecsvarady, Z.; Dormandy, J.A. 1991: Platelet-induced granulocyte aggregation in vitro. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(6): 699-703
Cohen, R.A. 1985: Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine. Journal of Clinical Investigation 75(1): 286-292
Baker, M.A.; Taub, R.N. 1976: Platelet-induced tolerance in the production of heteroantisera to human leukemia-associated antigens. Journal of Immunological Methods 10(2-3): 171-175
Jobin, F. 1978: Platelet-inhibiting drugs. L'Union Medicale du Canada 107(2): 163-6,171-7
Genton, E.; Gent, M.; Hirsh, J.; Harker, L.A. 1975: Platelet-inhibiting drugs iee parts). New England Journal of Medicine 293(24): 1236-1240
Genton, E.; Gent, M.; Hirsh, J.; Harker, L.A. 1975: Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). New England Journal of Medicine 293(25): 1296-1300
Chesebro, J.H.; Fuster, V. 1986: Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations. Cardiology 73(4-5): 292-305
Fuster, V.; Adams, P.C.; Badimon, J.J.; Chesebro, J.H. 1987: Platelet-inhibitor drugs' role in coronary artery disease. Progress in Cardiovascular Diseases 29(5): 325-346
Chesebro, J.H.; Steele, P.M.; Fuster, V. 1985: Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism. Postgraduate Medicine 78(1): 48-50 57-71
Donadio, J.V.; Ilstrup, D.M.; Holley, K.E.; Romero, J.C. 1988: Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study. Mayo Clinic Proceedings 63(1): 3-15
McCollum, C.N.; Goldman, M. 1985: Platelet-inhibitory therapy in reconstructive arterial surgery. Advances in Prostaglandin Thromboxane and Leukotriene Research 13: 301-309
Herzberg, M.C.; Erickson, P.R.; Kane, P.K.; Clawson, D.J.; Clawson, C.C.; Hoff, F.A. 1990: Platelet-interactive products of Streptococcus sanguis protoplasts. Infection and Immunity 58(12): 4117-4125
Eckel, R.H.; Crowell, E.B.; Waterhouse, B.E.; Bozdech, M.J. 1977: Platelet-latelet-. Archives of Internal Medicine 137(6): 735-737
Kahn, R.A.; Coburn, T. 1977: Platelet-leukapheresis technics. Transfusion 17(4): 397-398
Swank, R.L. 1977: Platelet-leukocyte aggregates. An evaluation and discussion. Bibliotheca Anatomica 1977(16 Pt 2): 475-477
Hirafuji, M.; Shinoda, H. 1991: Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. British Journal of Pharmacology 103(2): 1333-1338
Coëffier, E.; Joseph, D.; Prévost, M.C.; Vargaftig, B.B. 1987: Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. British Journal of Pharmacology 92(2): 393-406
Jungi, T.W.; Spycher, M.O.; Nydegger, U.E.; Barandun, S. 1986: Platelet-leukocyte interaction: selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes, and related cell lines. Blood 67(3): 629-636
Ratliff, N.B.; Gerrard, J.M.; White, J.G. 1979: Platelet-leukocyte interactions following arterial endothelial injury. American Journal of Pathology 96(2): 567-580
Davies, G.G.; Wells, D.G.; Mabee, T.M.; Sadler, R.; Melling, N.J. 1992: Platelet-leukocyte plasmapheresis attenuates the deleterious effects of cardiopulmonary bypass. Annals of Thoracic Surgery 53(2): 274-277
Mehta, J.L.; Nicolini, F.A.; Donnelly, W.H.; Nichols, W.W. 1992: Platelet-leukocyte-endothelial interactions in coronary artery disease. American Journal of Cardiology 69(7): 8b
Kŏno, N.; Chen, T.P.; Toyama, K.; Ogawa, T.; Mizokami, T. 1977: Platelet-like bodies in urine of patients with idiopathic thrombocytopenic purpura. Japanese Journal of Clinical Hematology 18(8): 973-978
Kono, N.; Toyama, K.; Chen, T.P.; Suzawa, N.; Mizokami, T. 1978: Platelet-like bodies in urine of patients with leukaemia. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 69(4): 443-447
Kono, N.; Suzawa, N.; Mizokami, T. 1977: Platelet-like body count in urine of normal adult. Nihon Jinzo Gakkai Shi 19(10): 801-807
Vargaftig, B.B.; Lefort, J.; Prancan, A.V.; Chignard, M.; Benveniste, J. 1979: Platelet-lung in vivo interactions: an artifact of a multi-purpose model?. Haemostasis 8(3-5): 171-182
Flores, N.A.; Seghatchian, M.J.; Sheridan, D.J. 1991: Platelet-mediated alterations in cardiac cellular electrophysiology. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(2): 367-371
Fass, R.J.; Copelan, E.A.; Brandt, J.T.; Moeschberger, M.L.; Ashton, J.J. 1987: Platelet-mediated bleeding caused by broad-spectrum penicillins. Journal of Infectious Diseases 155(6): 1242-1248
Kruth, H.S. 1985: Platelet-mediated cholesterol accumulation in cultured aortic smooth muscle cells. Science 227(4691): 1243-1245
Walsh, P.N. 1985: Platelet-mediated coagulant protein interactions in hemostasis. Seminars in Hematology 22(3): 178-186
Bykovskaya, S.N.; Bolvacheva, A.V.; Kiselevsky, M.V.; Khaylenko, V.A.; Bykovsky, A.F. 1991: Platelet-mediated cytotoxicity and its enhancement by platelet activating factor. Biomedicine and PharmacoTherapy 45(7): 279-288
Slezak, S.; Symer, D.E.; Shin, H.S. 1987: Platelet-mediated cytotoxicity. Role of antibody and C3, and localization of the cytotoxic system in membranes. Journal of Experimental Medicine 166(2): 489-505
Curtiss, L.K.; Dyer, C.A.; Banka, C.L.; Black, A.S. 1990: Platelet-mediated foam cell formation in atherosclerosis. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 13(4): 189-195
Mlczoch, J.; Tucker, A.; Weir, E.K.; Reeves, J.T.; Grover, R.F. 1978: Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism: reduction by platelet inhibition. Chest 74(6): 648-653
Mlczoch, J.; Reeves, J.T.; Grover, R.F. 1977: Platelet-mediated pulmonary hypertension: reduction by platelet inhibition. Progress in Biochemical Pharmacology 13: 344-348
Cooley, B.C. 1991: Platelet-mediated thrombosis in microvascular surgery. Plastic and Reconstructive Surgery 87(5): 993-994
Johnson, P.C. 1990: Platelet-mediated thrombosis in microvascular surgery: new knowledge and strategies. Plastic and Reconstructive Surgery 86(2): 359-367
De Clerck, F.; Van Gorp, L.; Beetens, J.; Reneman, R.S. 1985: Platelet-mediated vascular permeability in the rat: a predominant role for 5-hydroxytryptamine. Thrombosis Research 38(4): 321-339
Boukerche, H.; Berthier-Vergnes, O.; Tabone, E.; Doré, J.F.; Leung, L.L.; McGregor, J.L. 1989: Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. Blood 74(2): 658-663
Fuhrman, B.; Brook, J.G.; Aviram, M. 1989: Platelet-modified LDL: uptake and metabolism in macrophages. Harefuah 117(7-8): 177-181
Aviram, M.; Maor, I.; Rosenblat, M.; Dankner, G.; Brook, J.G. 1988: Platelet-modified lipoprotein induced by thrombin: effect of whole blood and plasma. Israel Journal of Medical Sciences 24(4-5): 193-200
Aviram, M.; Fuhrman, B.; Keidar, S.; Maor, I.; Rosenblat, M.; Dankner, G.; Brook, G. 1989: Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation. Journal of Clinical Chemistry and Clinical Biochemistry 27(1): 3-12
Aviram, M. 1987: Platelet-modified low-density lipoproteins: studies in normal subjects and in patients with homozygous familial hypercholesterolemia. Clinical Biochemistry 20(2): 91-95
Faraj, B.A.; Newman, S.L.; Caplan, D.B.; Ahmann, P.A.; Kutner, M.; Ali, F.M.; Lindahl, J.A. 1985: Platelet-monoamine oxidase activity in Reye's syndrome. Journal of Pediatric Gastroenterology and Nutrition 4(4): 532-536
Kazura, J.W. 1989: Platelet-neutrophil interaction: modulation of the inflammatory response. Journal of Laboratory and Clinical Medicine 114(5): 469-470
Marcus, A.J.; Safier, L.B.; Ullman, H.L.; Islam, N.; Broekman, M.J.; Falck, J.R.; Fischer, S.; von Schacky, C. 1988: Platelet-neutrophil interactions in the eicosanoid pathway. Advances in Experimental Medicine and Biology 243: 31-36
Marcus, A.J.; Safier, L.B.; Ullman, H.L.; Islam, N.; Broekman, M.J.; Falck, J.R.; Fischer, S.; von Schacky, C. 1988: Platelet-neutrophil interactions. (12S)-hydroxyeicosatetraen-1,20-dioic acid: a new eicosanoid synthesized by unstimulated neutrophils from (12S)-20-dihydroxyeicosatetraenoic acid. Journal of Biological Chemistry 263(5): 2223-2229
Von Schacky, C.; Marcus, A.J.; Safier, L.B.; Ullman, H.L.; Islam, N.; Broekman, M.J.; Fischer, S. 1990: Platelet-neutrophil interactions. 12S,20- and 5S,12S-dihydroxyeicosapentaenoic acids: two novel neutrophil metabolites from platelet-derived 12S-hydroxyeicosapentaenoic acid. Journal of Lipid Research 31(5): 801-810
Bazzoni, G.; Dejana, E.; Del Maschio, A. 1991: Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 76(6): 491-499
Faint, R.W. 1992: Platelet-neutrophil interactions: their significance. Blood Reviews 6(2): 83-91
Butruille, Y.A.; Leonard, E.F.; Litwak, R.S. 1975: Platelet-platelet interactions and non-adhesive encounters on biomaterials. Transactions - American Society for Artificial Internal Organs 21: 609-616
Morton, L.F.; Fitzsimmons, C.M.; Rauterberg, J.; Barnes, M.J. 1987: Platelet-reactive sites in collagen. Collagens i and IIi possess different aggregatory sites. Biochemical Journal 248(2): 483-487
Morton, L.F.; Peachey, A.R.; Barnes, M.J. 1989: Platelet-reactive sites in collagens type i and type III. Evidence for separate adhesion and aggregatory sites. Biochemical Journal 258(1): 157-163
Barnes, M.J.; MacIntyre, D.E. 1979: Platelet-reactivity of isolated constituents of the blood vessel wall. Haemostasis 8(3-5): 158-170
DelRossi, A.J.; Cernaianu, A.C.; Vertrees, R.A.; Wacker, C.J.; Fuller, S.J.; Cilley, J.H.; Baldino, W.A. 1990: Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 100(2): 281-286
Idell, S.; Maunder, R.; Fein, A.M.; Switalska, H.I.; Tuszynski, G.P.; McLarty, J.; Niewiarowski, S. 1989: Platelet-specific alpha-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome. Chest 96(5): 1125-1132
Luzzatto, G.; Cella, G. 1992: Platelet-specific proteins in myeloproliferative disorders. Acta Haematologica 87(4): 216-217
Ostermann, G.; Kertscher, H.P.; Till, U. 1985: Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. Biomedica Biochimica Acta 44(2): K17-K23
Steele, P.; Rainwater, J.; Vogel, R.; Genton, E. 1978: Platelet-suppressant therapy in patients with coronary artery disease. JAMA 240(3): 228-231
Watson, W.J.; Chang, T.M. 1975: Platelet-surface interaction: effects of dextran 70 on platelet retention in extracorporeal surfaces. Biomaterials Medical Devices and Artificial Organs 3(4): 489-502
Seyfert, U.T.; Hauck, W.; Berger, H.; Böhm, D.; Zankl, H.; Albert, F.W. 1990: Platelet-tumor cell interaction. Folia Haematologica 117(5): 685-697
Yahalom, J.; Eldor, A.; Biran, S.; Fuks, Z.; Vlodavsky, I. 1985: Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 3(3): 211-225
Costantini, V.; Fuschiotti, P.; Allegrucci, M.; Agnelli, G.; Nenci, G.G.; Fioretti, M.C. 1988: Platelet-tumor cell interaction: effect of prostacyclin and a synthetic analog on metastasis formation. Cancer ChemoTherapy and Pharmacology 22(4): 289-293
Takahashi, H.; Tatewaki, W.; Hanano, M.; Shibata, A. 1987: Platelet-type von Willebrand disease platelet aggregating factor: a novel functional assay of von Willebrand factor. Thrombosis Research 48(4): 475-485
Zharov, E.I.; Styrova, T.K.; Vertkin, A.L.; Martynov, A.I.; Galichenko, I.V. 1991: Platelet-vascular, plasma hemostasis and transient myocardial ischemia. Kardiologiia 31(8): 86-90
Murray, J.J.; Nowak, J.; Oates, J.A.; FitzGerald, G.A. 1990: Platelet-vessel wall interactions in individuals who smoke cigarettes. Advances in Experimental Medicine and Biology 273: 189-198
Monsen, C.H.; Adams, P.C.; Badimon, L.; Chesebro, J.H.; Fuster, V. 1987: Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty. Zeitschrift für Kardiologie 76(Suppl 6): 23-28
Adams, P.C.; Fuster, V.; Badimon, L.; Badimon, J.J.; Chesebro, J.H. 1987: Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategies. American Journal of Cardiology 60(12): 9g
Vados, W.; Thompson, H.; Scott, E. 1987: Plateletapheresis using single vein access: a comparison of Haemonetics V-50 and Fenwal CS-3000 blood cell separators. Vox Sanguinis 52(3): 195-199
Kretschmer, V.; Middelbeck, T.; Gerlach, A.; Göddecke, W.; Söhngen, D.; Prinz, H.; Pflüger, H.H. 1990: Plateletapheresis with the new cell separator AS-104. Beitrage Zur Infusionstherapie 26: 117-122
Pennisi, S.; Del Fabro, E. 1987: Plateletapheresis with "Haemonetics 30" through a new three-way reinfusion set. International Journal of Artificial Organs 10(1): 57-60
Davies, G.G.; Wells, D.G.; Mabee, T.M.; Sadler, R.; Ruffcorn, M.; Dooley, J.B. 1992: Plateletpheresis and the cost of heart operations. Annals of Thoracic Surgery 53(5): 943-944
Davies, G.G.; Wells, D.G.; Sadler, R.; Mabee, T.M.; Ruffcorn, M.; Dooley, J.B. 1992: Plateletpheresis and transfusion practice in heart operations. Annals of Thoracic Surgery 54(5): 1020
Larison, J.; Fatteh, M.M. 1978: Plateletpheresis as a preventive measure to complications of asymptomatic cases of idiopathic thrombocythemia. Journal of the Medical Association of Georgia 67(4): 296-297
Valbonesi, M.; Frisoni, R.; Capra, C.; Lercari, G.; Fella, M.; Pittaluga, P. 1988: Plateletpheresis concentrates produced in 30 minutes along with plasma and packed red cells: preliminary results. Journal of Clinical Apheresis 4(4): 152-154
Strates, B.S. 1976: Plateletpheresis vs plateletapheresis or thrombocytapheresis. JAMA 236(20): 2284
McLeod, B.C.; McKenna, R.; Viernes, A.; Reed, S.; Owens, E.A.; Matayoshi, D.; Moore, R.C. 1991: Plateletpheresis with the COBE spectra single needle access option. Journal of Clinical Apheresis 6(1): 24-27
Valbonesi, M.; Frisoni, R.; Fella, M.; Capra, C.; Malfanti, L.; Ferrari, M.; Zia, S.; Florio, G.; Nickel, H. 1991: Plateletpheresis with the new Fresenius AS 104 blood cell separator. Journal of Clinical Apheresis 6(2): 84-87
Luboldt, W.; Moog, R. 1991: Plateletpheresis with the new cell separator a 201 (Baxter). Beitrage Zur Infusionstherapie 28: 195-200
Puig, L.; Mazzara, R.; Gelabert, A.; Castillo, R. 1986: Plateletpheresis: a comparative study of six different protocols. Journal of Clinical Apheresis 3(2): 129-132
Warkentin, P.I. 1987: Plateletpheresis: an invaluable blood resource. Cleveland Clinic Journal of Medicine 54(5): 381-383
Edmeads, J. 1987: Platelets (again). Headache 27(5): 244-245
Panella, T.J.; Peters, W.; White, J.G.; Hannun, Y.A.; Greenberg, C.S. 1990: Platelets acquire a secretion defect after high-dose chemotherapy. Cancer 65(8): 1711-1716
Data, R.E.; Williams, S.B.; Roberts, D.D.; Gralnick, H.R. 1991: Platelets adhere to sulfatides by von Willebrand factor dependent and independent mechanisms. Thrombosis and Haemostasis 65(5): 581-587
Kaplan, J.E.; Moon, D.G.; Weston, L.K.; Minnear, F.L.; Del Vecchio, P.J.; Shepard, J.M.; Fenton, J.W. 1989: Platelets adhere to thrombin-treated endothelial cells in vitro. American Journal of Physiology 257(2 Part 2): H423-H433
Kekomäki, R.; Penttinen, K. 1979: Platelets and 125I-labelled staphylococcal protein a in the detection of immune complexes in serum. Journal of Clinical and Laboratory Immunology 1(4): 305-309
Naum, C.C.; Kaplan, S.S.; Basford, R.E. 1991: Platelets and ATP prime neutrophils for enhanced O2- generation at low concentrations but inhibit O2- generation at high concentrations. Journal of Leukocyte Biology 49(1): 83-89
Hu, S. 1988: Platelets and adult respiratory distress syndrome. Sheng Li Ke Xue Jin Zhan 19(4): 324-327
Vericel, E.; Croset, M.; Sedivy, P.; Courpron, P.; Dechavanne, M.; Lagarde, M. 1988: Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thrombosis Research 49(3): 331-342
Vericel, E.; Croset, M.; Perrot, L.; Renaud, S.; Lagarde, M. 1988: Platelets and aging. II--Plasma lipoproteins and fatty acid profiles. Thrombosis Research 49(5): 451-462
Frishman, W.H.; Miller, K.P. 1986: Platelets and antiplatelet therapy in ischemic heart disease. Current Problems in Cardiology 11(2): 69-136
Wargovich, T.J.; Nichols, W.W.; Mehta, J.L. 1987: Platelets and arachidonic acid derivatives in myocardial ischemia in animal models. Cardiovascular Clinics 18(1): 115-133
Page, C.P. 1991: Platelets and asthma. Annals of the new York Academy of Sciences 629: 38-47
Mauco, G. 1987: Platelets and atherogenesis. Archives des Maladies du Coeur et des Vaisseaux 80 Spec No: 37-42
Malmgren, R. 1986: Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets. Psychopharmacology 90(3): 384-389
Leira, R. 1991: Platelets and cerebral ischemia. Neurologia 6(2): 39-40
Martinez-Lavin, M.; Pineda, C.; Vazquez-Abad, D. 1988: Platelets and clubbing. Lancet 1(8588): 761
Meade, T.W. 1985: Platelets and coronary disease. British Medical Journal 290(6472): 933-934
Sheehy, T.W. 1976: Platelets and drugs. Journal of the Medical Association of the State of Alabama 45(9): 29-34
Maclouf, J.; Murphy, R.C.; Henson, P.M. 1989: Platelets and endothelial cells contribute to the production of LTC4 by transcellular metabolism with neutrophils. Advances in Prostaglandin Thromboxane and Leukotriene Research 19: 259-262
Reiss, R.F.; Katz, A.J. 1976: Platelets and factor VIIi as functions of blood collection time. Transfusion 16(3): 229-231
Green, D.; Potter, E.V. 1977: Platelets and factor VIII in von Willebrand's disease. New England Journal of Medicine 296(23): 1357
Joist, J.H. 1977: Platelets and fibrinolysis. Thrombosis and Haemostasis 38(4): 955-962
Sevitt, S. 1986: Platelets and foam cells in the evolution of atherosclerosis. Histological and immunohistological studies of human lesions. Atherosclerosis 61(2): 107-115
Cameron, J.S. 1977: Platelets and glomerulonephritis. Nephron 18(5): 253-258
Erne, P.; Resink, T.J.; Bürgisser, E.; Bühler, F.R. 1985: Platelets and hypertension. Journal of Cardiovascular Pharmacology 7 Suppl. 6: S103-S108
Trudinger, B.J. 1976: Platelets and intrauterine growth retardation in pre-eclampsia. British Journal of Obstetrics and Gynaecology 83(4): 284-286
Solomons, C.C. 1986: Platelets and malignant hyperthermia. Anesthesiology 65(1): 100-101
Vincent, J.E.; Bonta, I.L.; Zijlstra, F.J. 1977: Platelets and mediators in the carrageenin rat paw oedema. Agents and Actions. Supplements 2: 41-46
Schick, P.K.; Stormorken, H.; Hellem, A. 1985: Platelets and megakaryocytes. I. Comments and dedication to Arvid Hellem. Seminars in Hematology 22(2): 123-124